Skip to main content
PLOS One logoLink to PLOS One
. 2026 Jan 12;21(1):e0340025. doi: 10.1371/journal.pone.0340025

Effectiveness of clinical decision support in fall prevention among older adults: A systematic review and meta-analysis

Rune Solli 1,*, Nina Rydland Olsen 2, Linda Aimée Hartford Kvæl 1,3, Stijn Van de Velde 4, Are Hugo Pripp 1, Signe Agnes Flottorp 5, Therese Brovold 1
Editor: Sascha Köpke6
PMCID: PMC12795367  PMID: 41525339

Abstract

Background

Systematic use of Clinical Decision Support (CDS), which provides timely information to assist healthcare practitioners in decision-making, is recommended in the implementation of fall prevention among older adults. This systematic review aimed to evaluate the effects of CDS for fall prevention on healthcare practitioners’ adherence to recommended practice, medication outcomes, and patient outcomes.

Methods

We searched Medline, EMBASE, CINAHL, Cochrane Library, Web of Science, AMED, PEDro, and Google Scholar from the earliest available dates through January 2025. We included randomised and non-randomised studies that directly compared interventions consisting of CDS presented on-screen or on paper to healthcare practitioners aiming to prevent falls in persons aged 65 years or older. We analysed healthcare practitioner performance, medication review and prescribing, fall risk, fall rate, and fall injury rate as primary outcomes. Two reviewers independently screened studies and assessed for risk of bias. We synthesised results using meta-analyses and vote-counting based on direction of effect, when possible, otherwise narratively, and we rated the certainty of the evidence using the GRADE approach.

Results

Of 25 included studies, 20 were randomised and five were non-randomised. Most CDS tools supported healthcare practitioners in performing multifactorial fall risk assessments and follow-up interventions based on identified risks (60%) and most were delivered electronically (60%). CDS may improve healthcare practitioners’ adherence to recommended practice (all eight comparisons favouring CDS; 95% confidence interval [CI] 68% to 100%; low certainty) and likely improve medication review and prescribing (all nine comparisons favouring CDS; 95% CI 70% to 100%; moderate certainty), although the effect sizes are uncertain. CDS may reduce fall risk, but the effect may be small (odds ratio 0.93; 95% CI 0.81 to 1.01; low certainty). CDS likely reduces fall rates in hospitals or residential care (rate ratio [RaR] 0.74; 95% CI 0.63 to 0.88; moderate certainty) and in patients aged 80 years or older (RaR 0.72; 95% CI 0.61 to 0.86; moderate certainty). CDS may reduce fall rates in community-dwelling older adults (RaR 0.97; 95% CI 0.93 to 1.00; moderate certainty) and in patients aged between 65 and 80 years (RaR 0.92; 95% CI 0.84 to 1.01; low certainty), though the effects in both of these subgroups may be small. CDS may reduce fall injury rates in older adults aged between 65 and 80 years (RaR 0.80; 95% CI 0.59 to 1.09; low certainty). The evidence on fall injury rates in patients aged 80 years or older was very uncertain.

Conclusion

CDS likely enhances healthcare practitioners’ performance in fall prevention among older adults; however, the effect sizes remain unknown. Although CDS may improve patient outcomes in fall prevention, both the effect sizes and the certainty of evidence vary. Results from this study may inform the planning and implementation of CDS in fall prevention. Future studies should strive for clearer reporting of CDS design factors to allow for an evaluation of which factors may influence the success of CDS interventions in fall prevention.

Trial registration

Registration: PROSPERO, CRD42021250500.

Introduction

Falls are a major cause of morbidity and mortality among community-dwelling older adults aged 65 years or older [13]. Annually, one in three older adults experiences a fall, which can lead to significant health loss and increased care needs [15]. Globally, fall-related injuries are one of the most expensive conditions in terms of economic expenditures [46]. Identified risk factors for falls include a history of falls, higher age, female sex, and fear of falling [7,8]. A range of cost-effective interventions has been shown to prevent falls and reduce the incidence of fall-related injuries in older adults [911]. These interventions include muscle strength and balance training, home safety assessments and modifications, and medication adjustments [9,10]. Falls are often underreported, as older adults may not report falls unprompted [12,13]. The World Falls Guidelines 2022 (WFG2022) [14] emphasise the need to identify older adults at increased fall risk. They recommend that all older adults receive advise on fall prevention and physical activity.

Despite scientific support for the implementation of fall-prevention recommendations for older adults, the systematic uptake of evidence-based fall prevention practices has been slow [1417] Consequently, fall rates and fall-related mortality have not declined [3,18,19]. The WFG2022 recommend the systematic use of Clinical Decision Support (CDS) in fall prevention to identify older adults at increased risk of falling and to facilitate fall risk assessments and interventions. CDS is an implementation strategy found to improve healthcare practitioners’ adherence to clinical guidelines [20]. CDS is defined as computerised or non-computerised tools that combine health-related and medical information with individual patient information to support clinical decision-making [21,22]. CDS has the potential to assist healthcare practitioners in identifying older adults at increased fall risk [2325] as well as in individualising fall prevention interventions based on identified risk factors [24,2628].

Several systematic reviews have evaluated the effects of CDS used by healthcare practitioners across a variety of settings, demonstrating small to moderate positive effects [20,2937]. Generally, the use of CDS may improve the implementation of clinical practice guidelines [20] and the performance of nurses and allied health professionals [29,34,35]. In addition, CDS has been shown to improve hospital care for older patients [30], medication outcomes in older adults [31,32], and medication outcomes in adults more broadly [36,37]. The effect of CDS on patient outcomes, however, appears less certain [35]. While CDS may not significantly affect mortality, it may moderately improve morbidity outcomes [33] and a variety of other patient outcomes [36]. Two systematic reviews found that CDS may help prevent falls in nursing homes [29] and in hospitals [30]. However, these reviews did not include several known studies on the effects of CDS in fall prevention [38,39], and no statistical syntheses were conducted. Overall, findings from systematic reviews indicate that CDS may provide important benefits for healthcare practitioners’ performance and patient outcomes. However, no systematic review to date has specifically investigated the effects of CDS on healthcare practitioners’ performance and patient outcomes in the context of fall prevention.

Objectives

This systematic review aimed to evaluate the effects of CDS for fall prevention on healthcare practitioners’ adherence to recommended practice, medication outcomes, and on patient outcomes.

Materials and methods

Protocol and registration

The review protocol was drafted and finalised in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for study protocols (PRISMA-P) [40] and was registered in the PROSPERO international prospective register of systematic reviews (identification number CRD42021250500) prior to commencing the systematic review. We followed the recommendations in the Cochrane Handbook [41] and the guidance from the Cochrane Effective Practice and Organisation of Care (EPOC) [42]. Reporting of this systematic review adhered to the standards of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [43]. See S1 Table for the populated PRISMA checklist. See S2 Table for differences between the protocol and the review.

Eligibility criteria

We included studies evaluating the effects of CDS interventions designed to support HCPs in making decisions to prevent falls in older adults. Studies conducted in any healthcare setting or in the homes of older adults were eligible for inclusion. We included randomised and non-randomised controlled trials, controlled before-after studies, and interrupted time-series studies. Detailed eligibility criteria are presented in Table 1.

Table 1. Study eligibility criteria.

Inclusion criteria Exclusion criteria
Participants Healthcare practitioners (nurses, physiotherapists, general practitioners, occupational therapists, nursing assistants, pharmacists, physicians, primary care providers, paramedics) Studies of CDS used by students.
Intervention CDS used by healthcare practitioners in fall prevention interventions. We included both computerised and non-computerised CDS interventions. Studies where CDS was not part of the intervention in at least one study group or arm.
Comparison Usual care or no treatment.
Outcomes We included studies that reported at least one primary or secondary outcome.

Primary:

• Healthcare practitioner performance: Adherence to recommended practice and adherence to recommended medication prescribing and review.

• Patient outcomes: Rate of falls (i.e., number of falls per unit of follow-up time); risk of falling (i.e., the number of older adults who had one or more falls); and fall injuries.

Secondary:

• Deaths and hospitalisations.
Studies that did not report at least one primary or secondary outcome.
Design RCTs: IRPGT and CRT; NRCTs; CBA studies; and ITS studies [42]. Uncontrolled before-after, cross-sectional, case-control, and cohort studies; as well as protocols, editorials, opinion papers, and conference abstracts.

Studies without a control group, except for ITS studies with multiple data points collected before and after the implementation of the intervention.
Setting Any healthcare setting or in the homes of older adults. Studies conducted in a setting other than a healthcare institution or in the homes of older adults.

CDS: Clinical Decision Support; RCT: Randomised controlled trial; IRPGT: Individually-randomised parallel-group trial; CRT: Cluster-randomised trial; NRCT: Non-randomised controlled trial; CBA: Controlled before-after study; ITS: Interrupted time-series.

Information sources and search strategy

We searched the following databases from the earliest available date through January 2025: MEDLINE (Ovid), EMBASE (Ovid), CINAHL (EBSCOhost), The Cochrane Library, Web of Science, and AMED (Ovid). Supplemental searches were performed in Google Scholar (S3 Table). The literature search strategy was developed in cooperation with two librarians from the Literature Search Resource/Expert Group at Oslo Metropolitan University (OsloMet). The searches were developed to be highly sensitive and included terms synonymous with the fundamental concepts underlying CDS (e.g., decision rules, reminder systems, algorithms), falls (e.g., accidental falls, slip), and fall prevention (e.g., accident prevention, safety management). We did not impose any language or study design restrictions on the literature searches. To maximise the sensitivity of the search and capture a broader range of potentially relevant studies, study design was not restricted in the search strategy. One reviewer (RS) used the advanced search feature in the Physiotherapy Evidence Database (PEDro) to conduct manual searches for relevant clinical trials. Additionally, we searched the reference lists of the included articles and relevant systematic reviews. Cited reference searching for all included articles was carried out in Web of Science. See S3 Table for the complete search strategy.

Selection process

Search results were imported into EndNote, where duplicates were removed. Next, all unique abstracts and full text articles were uploaded to the Covidence systematic review software [44]. Two reviewers (RS and either TB, NRO, or LAHK) independently screened titles, abstracts, and full texts against the eligibility criteria. Any disagreements were resolved through consensus or, if needed, by the decision of a third reviewer. Consensus between reviewers was required at both the title and abstract screening stage, as well as during the full-text screening stage.

Data collection process

We used an adapted version of the EPOC data collection form to extract relevant data from the included studies. The data extraction form was piloted on three reports by two reviewers. One reviewer (RS) independently extracted the data, and another reviewer (TB) checked the extracted data against five arbitrarily selected papers. Any disagreements between reviewers were resolved by consensus, with consultation from a third reviewer if necessary. To address missing outcome data, we contacted the corresponding authors of eight included reports via email. If no responses were received, follow-up emails were sent after two weeks, with a maximum of three email attempts per author. Our efforts to obtain missing data were successful in four instances. All data used in the analyses were obtained directly from primary sources or through successful correspondence with authors, with no data imputation performed.

Data items

Outcomes.

For healthcare practitioner performance, we sought data on adherence to recommended practices, including the provision of specific advice, delivery of specific interventions, and adherence to referral guidelines [42]. We also collected data on medication outcomes, including medication review [45] and prescribing. For patient outcomes, we included fall risk, fall rate, and fall injury rate. Fall risk refers to the proportion of individuals who experienced at least one fall over a specific period, representing the likelihood of falling at the individual level. Fall rate and fall injury rate refer to the total number of falls or fall injuries per unit of time, e.g., per 1,000 person-years, accounting for multiple falls per individual. Fall injuries included both minor injuries, such as bruises or abrasions, and serious injuries, such as fractures or those requiring medical attention [46]. We also sought data for deaths and hospitalisations. If multiple results were reported in a study, we prioritised the primary outcome as specified by the authors or the outcome used for sample size calculation. If primary outcomes were not clearly identified, we prioritised results deemed to be most relevant to the research question, those indicating drug overuse rather than misuse or underuse (due to the significant fall risk imposed by polypharmacy [47]), and results based on whole-group analyses rather than subgroup analyses.

Study characteristics.

We extracted the following data on study characteristics: authors, publication year, funding, country, design, setting, duration, healthcare practitioners delivering the intervention (type and number), and patients receiving the intervention (number, sex, age).

Interventions and CDS.

We extracted the characteristics of experimental and control interventions using the Template for Intervention Description and Replication (TIDieR) checklist [48], and using domains 1 and 3 from the intervention complexity assessment tool for systematic reviews (iCAT_SR) [49]. Interventions were categorised into 1) manual fall risk assessment and interventions based on CDS; 2) medication review and recommendations made to physician; 3) automatically generated fall risk based on prediction models and recommended interventions; 4) guided medication dosing using computerised CDS; and 5) computerised CDS presented to paramedics on hand-held tablets [50,51]. Design factors of CDS tools were extracted using the GUideline Implementation with DEcision Support (GUIDES) framework [51] and elements from the two-stream model [52].

Study risk of bias assessment

Two review authors independently assessed risk of bias (RoB) for outcomes indicating healthcare practitioner performance, fall rates, fall risk, and fall injuries. We used the Revised Cochrane Risk of Bias tool for randomised trials (RoB 2.0) [53] for included RCTs, and the Risk Of Bias In Non-randomised Studies of Interventions (ROBINS-I) tool [54,55] for included non-randomised studies. Any disagreements between reviewers were resolved by consensus, and if necessary, a third reviewer was consulted.

Synthesis methods and effect measures

Healthcare practitioner performance.

We performed two analyses related to healthcare practitioner performance, both of which used vote-counting based on direction of effect [41,56]. In the analysis of adherence to recommended practice, we included outcomes indicating the use of recommended intervention components or adherence to the intervention protocol or to the referral guideline [42]. In the analysis of medication outcomes, we included outcomes indicating changes in the use of fall-risk-increasing drugs (FRIDs), polypharmacy, drug underuse, or drug-related problems [31]. To decide which results were eligible for the analyses, we tabulated each study result and compared it against the eligibility criteria. Each effect estimate was dichotomised into ‘favouring CDS’ or ‘favouring control’, based on the observed direction of effect alone. We used the sign test for differences in proportions and presented the proportion of results favouring CDS along with 95% confidence intervals (CIs) using the Wilson interval method [57]. The data used for analyses of healthcare practitioner performance outcomes are available in S1 Appendix.

Patient outcomes.

Data on fall risk, fall rate, and fall injury rate were pooled into meta-analyses in line with previous work [9,58]. We assumed that underlying study effects followed a normal distribution and used random effects models and restricted maximum likelihood (REML) estimation methods [59]. Stata, version 18.0, StataCorp, College Station, Texas [60], was used for all analyses and pooled results were presented in forest plots. Results were presented as odds ratios (OR) for fall risk, and as rate ratios (RaR) for fall rate and fall injury rate, along with 95% CIs. Variation between study results (heterogeneity) was assessed by means of a visual inspection of forest plots and the I2 statistic [59]. If I2 values were 50% or higher, we sought potential explanations for the heterogeneity using post hoc subgroup analyses by RoB (low or some concerns for RoB versus high or serious RoB), study setting (community-dwelling versus hospital or residential care), and patient age (mean age of < 80 years versus ≥ 80 years). If point estimates and confidence intervals were missing but other information was available, e.g., number of events and the follow-up time in both comparison groups, we used established formulas to estimate the point estimates and confidence intervals [61]. Only one outcome per study was included in the analyses to ensure independence between studies. The data used for meta-analyses are available in S2 Appendix. Control intervention fall risks, fall rates, and fall injury rates were derived from a US report on the epidemiology of falls among older adults [62], due to the limited reporting of absolute numbers in the studies included in this review. To report the absolute effects on fall risk, odds ratios were first converted to relative risks using the formula provided in appendix 3 of the Core GRADE 2 article [63].

Publication bias assessment

The possibility of publication bias was assessed through inspection of funnel plots of effect estimates against their standard errors for analyses that contained at least 10 effect estimates [41]. The Egger test for small-study effects and the trim-and-fill analysis were used for quantitative assessment of publication bias [64].

Assessment of certainty of the evidence

We judged the certainty of the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach [63,65,66], applied to each outcome from vote-counting analyses and meta-analyses. Despite extensive literature searches conducted with the assistance of two librarians at OsloMet, no minimal important difference (MID) values were identified for fall risk, fall rate, or fall injury rate. Certainty was therefore rated based on whether the true effect lies on the observed side of null, with the null effect used as the threshold. Relative and absolute effects were reported alongside plain-language statements, following recommendations from GRADE guidance [67,68].

Results

Study selection

Fig 1 presents an overview of the study selection process. The primary database searches identified 6,572 unique records, of which 6,527 were excluded after title and abstract screening. A total of 28 publications describing 25 unique studies were selected for inclusion [2328,38,39,6988]. S4 Table provides a summary of the excluded studies and the reasons for their exclusion.

Fig 1. PRISMA flow diagram.

Fig 1

Study characteristics

Study design, participants, and settings.

Table 2 presents an overview of the characteristics of the included studies. The 25 studies comprised 13 cluster-randomised trials (CRTs), seven individually randomised parallel group trials (IRPGTs), four non-randomised controlled trials (NRCTs), and one controlled before-after (CBA) study. The study duration was median (min–max) 12 (1–60) months. The interventions were primarily delivered by nurses (16 studies; 64%), physicians (15 studies; 60%), pharmacists (6 studies; 24%), and/or physiotherapists (4 studies; 16%) to a median of 1,433 patient participants, with sample sizes ranging from 312 to 46,245. Twelve studies (48%) had eligibility criteria related to an increased risk of falls, such as a history of previous falls or the use of fall-risk-increasing drugs. Most studies were conducted in hospitals (44%) or primary care practices (36%) and took place in North America (52%) or Europe (28%).

Table 2. Characteristics of included studies.
Author & year Country Design Setting Study duration (months) Healthcare practitioners Patients Outcomes
Aizen 2015 Israel CRT Rehabilitation geriatric hospital 6 Nurses

n = ?
Patients admitted to hospital

n = 508 (200 in CDS and 308 in CG), 52.2% female, mean 84.3 years
-Rate of falls
Barker 2016 Australia CRT Hospital 12 Nurses

n = ?
Patients admitted to hospital

n = 35,264 (17,698 in CDS and 17,566 in CG), 49.5% female, median 67.5 years
-Adherence to recommended practice

-Rate of falls

-Rate of fall injuries
Bhasin 2020 USA CRT Primary care practices 44 Nurses

n = ?
Community-dwelling at increased risk for fall injuries

n = 5,451 (2,802 in CDS and 2,649 in CG), 62% female, mean 79.7 years
-Rate of fall injuries
Blalock 2020 USA CRT Community pharmacies 24 Pharmacists

n = ?
Adults ≥65 years using either four or more chronic medications or ≥1 medication associated with increased fall risk, n = 3,213 (1,467 in CDS and 1,745 in CG) -Medication outcomes

-Risk of falling
Blum 2021 Switzerland, Netherlands, Belgium, Republic of Ireland CRT Hospitals 12 Physicians and pharmacists

n = ?
Adults years with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 drugs used long term)

n = 2,008 (963 in CDS and 1,045 in CG), 44.7% female, median 79 years
-Rate of falls

-Medication outcomes

-Mortality

-Hospital admissions
Byrne 2005 USA CBA Nursing homes 33 Nurses

n = 153
n = ?,? females, Mean age in IG: 82.5 (group 1) and 80.9 (group 2); in CG: 79.2 (group 5) and 82.2 (group 6) - Rate of falls
Carroll 2012 USA CRT Urban hospitals (academic medical centres & community hospitals) 6 Nurses

n = ?
Patients admitted during study period

n = 364,? female,? age
-Adherence to recommended practice
Dykes 2010 Patients admitted during study period

n = 10,264 (5,160 in CDS and 5,104 in CG), 54.5% female, mean 78.8 years (among patients 65 years or older)
-Rate of falls

-Rate of fall injuries

-Adherence to recommended practice
Clemson 2024 Australia CRT Primary care practices 12 Physicians

n = 75

Allied health professionals n = 342
Community-dwelling older adults who had had a fall in the past year or were concerned about falling

n = 560 (275 in CDS and 285 in CG), 67.9% female, mean 78.6 years
-Rate of falls

-Adherence to recommended practice
Dykes 2020 USA NRCT Hospital (academic medical centres) 42 Nurses

n = ?
Patients admitted during study period

n = 37,231 (17,948 in pre-intervention group and 19,283 in post-intervention group), 53.8% female, mean 60.8 years
-Rate of falls

-Rate of fall injuries
Elley 2008 New Zealand IRPGT Primary care practices 12 Nurses

n = 54
Adults who had fallen in the past 12 months

n = 312 (155 in CDS and 157 in CG), 68.9% female, mean 80.8 years
-Rate of falls
Ferrer 2014 Spain IRPGT Primary care practices 24 Physicians and nurses

n = ?
Community-dwelling older adults born in 1924 (85 years of age at study start)

n = 328 (164 in CDS and 164 in CG), 61.1% female
-Risk of falling

-Time to first, second, and recurrent falls

-Hospital admissions
Frankenthal 2014 Israel IRPGT Hospital (Chronic care geriatric facility) 12 Pharmacist

n = ?
Residents prescribed at least one medication

n = 359 (183 in CDS and 176 in CG), 66.6% female, mean 82.7 years
-Rate of falls

-Hospital admissions
Gallagher 2011 Ireland IRPGT University hospital 6 Physicians

n = ?
Patients admitted via the emergency department under care of a GP

n = 382 (190 in CDS and 192 in CG), 53.1% female, median 74.5 years (IG) and 77 (CG)
-Medication outcomes

-Risk of falling

-Hospital admissions
Ganz 2015 USA NRCT Primary care practices 24 Physicians, nurse practitioner, physician assistant

n = 44
Patients who screened positive for fall risk

n = 1,791 (1,187 in CDS and 604 in control), 72% female, mean 82.9 years
-Rate of fall injuries
Wenger 2010 12 Patients who screened positive for falls or fear of falling and UI:

n = 1,211 (586 in CDS and 625 in CG), 71.7% female, mean 83 years
-Adherence to recommended practice
Ganz 2022 USA CRT Primary care practices 60 Nurses

n = ?
Community-living persons at increased risk for serious fall injuries

n = 5,451 (2,802 in CDS and 2,649 in CG), 62% female, mean 79.7 years
-Rate of falls

-Rate of falls leading to medical attention

-Hospital admissions
Groshaus 2012 Canada NRCT Acute care hospitals 3 Nurses

n = ?
Patients residing on study units

n = ?,? female,? years
-Adherence to recommended practice

-Risk of falling
Healey 2004 UK CRT District general hospital 12 Nurses

n = ?
All older adults who received care in the wards during the study period

n = 1,654 (905 in CDS and 749 in CG), 60% female, mean 81.3 years
-Rate of falls

-Rate of fall injuries
Lightbody 2002 UK IRPGT University hospital 6 Nurses

n = ?
Older adults discharged from Accident and Emergency Department after a fall

n = 348 (171 in CDS and 177 in CG), 74.4% female, median 75 years
-Medication outcomes

-Risk of falling

-Rate of falls

-Hospital admissions
Logan 2021 UK CRT Long-term care homes 12 Care home staff

n = 3,609
Long-term care home residents in care homes for older adults

n = 1,657 (775 in CDS and 882 in CG), 67.9% female, mean 85 years
-Rate of falls

-Mortality
Mahoney 2007 USA IRPGT Home visits 12 Registered nurse, physical therapist, physician

n = ?
Community-dwelling adults with two falls in the past year or one fall in the previous two years with injury or balance problems

n = 349 (174 in CDS and 175 in CG), 78.5% female, mean 80 years
-Rate of falls

-Hospital admissions
Peterson 2007 USA IRPGT Tertiary care hospital 9 Physicians

n = 778
Inpatients ≥ receiving care on one of the order entry wards (i.e., emergency room, intensive care units, subacute units)

n = 2,981,? female, = years
-Adherence to recommended practice
Phelan 2024 USA CRT Primary care practices 18 Physicians Community-dwelling adults aged ≥ 60 years, prescribed at least 1 medication from any of 5 targeted medication classes (opioids, sedative-hypnotics, skeletal muscle relaxants, tricyclic antidepressants, and first-generation antihistamines for at least 3 consecutive months

n = 2,367 (1,106 in CDS and 1,261 in CG), 63% female, mean 70.6
-Time to first medically treated fall (risk of fall injuries)

-Medication outcomes
Snooks 2014 UK CRT Emergency ambulance services 1 Paramedics

n = 42
Community-dwelling older adults living in the catchment area of a participating falls service

n = 779 (436 in CDS and 343 in CG), 63.4% female, median 82.5 years
-Adherence to recommended practice

-Risk of falling

-Mortality

-Hospital admissions
Tamblyn 2012 Canada CRT Primary care practices 23 GPs

n = 81
Patients with a prescription for a psychotropic drug

n = 5,628 (2,887 in CDS and 2,741 in CG), 67.1% female, mean 75.2 years
-Medication outcomes

Weber 2008 USA CRT Primary care practices 15 Pharmacists and GPs

n = ?
Community-dwelling patients at risk for falls

n = 620 (413 in CDS and 207 in CG), 79.2% female, mean 76.9 years
-Risk of falling

-Medication outcomes
Wenger 2009 USA NRCT Primary care practices 32 Physicians

n = 40
Community-dwelling patients who had at least one of three geriatric conditions: falls and gait impairment, urinary incontinence, and cognitive impairment

n = 644 (357 in CDS and 287 in CG), 66% female, mean 81 years
-Adherence to recommended practice

CBA: Controlled Before-After study; CCDS: Computerised Clinical Decision Support; CDS: Clinical Decision Support group; CG: Control group; CRT: Cluster-Randomised Trial; ED: Emergency Department; GP: General Practitioner; IG: Intervention Group; ITS: Interrupted Time-Series study; IRPGT: Individually-Randomised Parallel-Group Trial; NRCT: Non-Randomised Controlled Trial; UI: Urinary Incontinence.

Interventions and CDS tools.

Table 3 presents an overview of the characteristics of the interventions and CDS tools assessed in the included studies. Most interventions (15 studies; 60%) delivered CDS to healthcare practitioners to aid with fall risk assessments, followed by an offer to the patient of specific fall prevention interventions. The majority of interventions (22 studies; 88%) consisted of more than one component delivered as a bundle, i.e., there was a defined order in the delivery of the components, such as conducting a medication review prior to implementing medication changes. Interventions were primarily directed at either one type of healthcare practitioner (12 studies; 48%) or at two or more types of healthcare practitioners within the same healthcare setting (11 studies; 44%). See S5 Table for a detailed description of the interventions. Most CDS tools were designed as algorithms presented as if-then statements or as checklists with risk factors for falls, followed by recommendations for fall prevention interventions that were either generated automatically or chosen manually from a list (68%). Regarding delivery methods, 15 CDS tools (60%) were electronic, three (12%) were delivered both electronically and on paper, two (8%) were paper-based, and for five studies (20%), the delivery method was unclear. Among the electronic CDS tools, nine (36%) included alerts, reminders, or prompts, while the others delivered decision support on demand. Control interventions included usual care (76%), usual care plus a falls information pamphlet (4%), usual care plus an offer of two social visits (4%), home safety visits (4%), paper-based CDS (4%), and no treatment (4%). One study (4%) failed to mention control. See S6 Table for a detailed description of the CDS design factors.

Table 3. Characteristics of interventions and Clinical Decision Support.
Study Type of intervention Active components n types of intervention deliverers Organisational levels CDS format CDS features
Aizen 2015 1 High 1: Nurses Low Electronic Risk assessment tool with intervention recommendations based on risk
Barker 2016 1 High 3: Nurse, site clinical leader, champion Intermediate Checklist with risk factors and recommended interventions; Reminders on the use of intervention components
Bhasin 2020, Ganz 2022 1 High 3: Nurse, primary care physician, pharmacist Intermediate Electronic Algorithm with risk factors and intervention recommendations
Blalock 2020 2 High 2: Pharmacist, primary care physician Intermediate Electronic Adapted STEADI algorithm with risk factors and intervention recommendations
Blum 2021 2 High 3: Pharmacist, hospital physician, general practitioner High Electronic Lists of FRIDs (STOPP/START criteria)
Byrne 2005 3 High 1: Nurse Low Electronic Automatically generated fall risk estimates and intervention recommendations
Carroll 2012, Dykes 2010 1 High 1: Nurse Low Electronic and paper-based Alerts printed on paper to hang over bed
Clemson 2024 1 High > 7: Primary care physicians, physiotherapists, occupational therapists, nurses, podiatrists, pharmacists, exercise physiologists, and other professions High Electronic and paper-based iSOLVE algorithm; Fall risk assessment checklist; GP fall risk assessment chart; Tailoring interventions to fall risk chart; Risk information automatically sent to GP; Case studies which illustrate the algorithm and tailoring options; Examples of how to talk with patients about falls
Dykes 2020 1 High 1: Nurse Low Electronic Checklist with risk factors and recommended interventions
Elley 2008 1 High 3: Nurse, trained practitioner, physiotherapist Intermediate Algorithm with risk factors and intervention recommendations
Ferrer 2014 1 High 2: Nurse, primary care physician Intermediate Algorithm with risk factors and intervention recommendations
Frankenthal 2014 2 High 2: Pharmacist, hospital physician Intermediate Electronic Lists of FRIDs (STOPP/START criteria)
Gallagher 2011 2 High 1: Hospital physician Low Lists of FRIDs (STOPP/START criteria)
Ganz 2015, Wenger 2010 1 High 3: Primary care physician, nurse, physician assistant Intermediate Electronic Medical record prompts
Groshaus 2012 1 High 1: Nurse Low Electronic Electronic order set
Healey 2004 1 High 1: Nurse Low Paper-based Checklist with risk factors and intervention recommendations
Lightbody 2002 1 High 1: Nurse Low Checklist with risk factors and intervention recommendations
Logan 2021 1 High 3: Nurse, physiotherapist, occupational therapist Intermediate Paper-based Checklist with risk factors and intervention recommendations
Mahoney 2007 1 High 3: Nurse, physiotherapist, primary care physician Intermediate Electronic Algorithm with automatically generated intervention recommendations
Peterson 2007 4 Low 1: Hospital physician Low Electronic Guided medication dosing; Prompts presented on-screen
Phelan 2024 2 Intermediate 1: Primary care physician Low Electronic Evidence-based pharmaceutical opinions; Deprescribing pearls with conversation starters
Snooks 2014 5 High 1: Paramedic Low Electronic Prompts to start assessment; Algorithm with automatically generated care plan
Tamblyn 2012 4 Low 1: Primary care physician Low Electronic Predictive model to automatically estimate risk of injury; Alerts when patient was prescribed a FRID; Graphics presenting risk estimates; Guided medication dosing
Weber 2008 2 High 3: Pharmacist, geriatrician, primary care physician Intermediate Electronic Guided medication dosing; Alerts with patient’s fall risk
Wenger 2009 1 High 3: Nurse, primary care physician, medical assistant Intermediate Electronic and paper-based Medical record prompts with suggestions for appropriate action

CDS: Clinical Decision Support; FRIDs: Fall-risk-increasing drugs; GP: General practitioner; STEADI: Stopping Elderly Accidents, DEaths, and Injuries; STOPP/START: Screening Tool of Older Person’s Prescriptions and Screening Tool to Alert doctors to Right Treatment.

Type of intervention:

1: Fall risk assessment and interventions based on CDS.

2: Medication review and recommendations made to physician.

3: Automatically generated fall risk based on prediction models, followed by recommended interventions.

4: Guided medication dosing using computerised CDS.

5: Computerised CDS presented to paramedics on hand-held tablets.

Active components (iCAT_SR domain 2):

High: More than one component and delivered as a bundle (clear order in the delivery of the components) (high level of complexity).

Intermediate: More than one component and delivered as a package (no specific order) (intermediate level of complexity).

Low: One component (low level of complexity).

Organisational levels and categories targeted by the intervention (iCAT_SR domain 3):

High: Intervention directed at two or more healthcare settings, e.g., primary care and hospitals (multi-level).

Intermediate: Intervention directed at two or more categories of healthcare practitioners within the same healthcare setting, e.g., nurse and physiotherapist in primary care (multi-category).

Low: Intervention directed at one category of healthcare practitioner, e.g., nurses (single category).

Risk of bias in included studies.

A detailed description of RoB assessments is available in S7 Table. We assessed a total of 40 results across five outcomes. Out of 33 results from randomised trials, 19 were judged to have high RoB, 10 had some concerns, and four were rated as having a low RoB. All seven results from non-randomised studies were judged to be at serious RoB, primarily owing to concerns for bias related to confounding.

Results of individual studies

Results from each individual study are available in S8 Table.

Healthcare practitioner performance

Adherence to recommended practice.

Five CRTs [24,25,28,69,86] and three NRCTs [78,80,88] reported results on adherence to recommended practice regarding fall prevention (Fig 2). Outcomes across these studies included fall risk documentation and provision of recommended intervention components. The median follow-up time was 7 months (range: 1–13 months). All eight results favoured the intervention (100%; 95% CI: 68% to 100%; p < 0.01). The certainty of evidence was low due to risk of bias (Table 4). Overall, these findings suggest that CDS may improve healthcare practitioners’ adherence to recommended practice in fall prevention.

Fig 2. Healthcare practitioner performance results.

Fig 2

FU: Follow-up; IQR: Interquartile range; DBI: Drug Burden Index; IG: Intervention group; CG: Control group; RoB: Overall risk of bias judgement. † Based on subgroup analysis and therefore not randomised. * Non-randomised study. Serious risk of bias based on ROBINS-I. Sign test: H0: n results favouring CDS = n results favouring control. Ha: n results favouring CDS ≠ n results favouring control.

Table 4. Summary of findings.
CDS interventions compared with usual care for HCPs in fall prevention among older adults
Population: HCPs, including nurses, physiotherapists, general practitioners, occupational therapists, nursing assistants, pharmacists, physicians, primary care providers, and paramedics

Settings: Hospitals, residential care, primary care, and the homes of older adults

Intervention: CDS targeted at HCPs

Comparison: Usual care
Outcomes

No of participants (studies)
Relative effects (95% CI) Anticipated absolute effects* (95% CI) Certainty of evidence
In control CDS interventions Difference
Adherence to recommended practice: fall risk assessments and interventions

Follow-up: median 7 (1–13) months

a (8)
b b b b ⊕⊕OO

Lowc

Due to very serious risk of bias
Adherence to recommended medication review and prescribing

Follow-up: median 9 (0–23) months

a (9)
b b b b ⊕⊕⊕O

Moderated

Due to risk of bias
Fall risk

Follow-up: median 9 (1–24) months

> 13,636e (10)
OR 0.93 (0.85 to 1.01) 287 per 1,000 273 per 1,000 (255–290) 14 fewer fallers per 1,000 (32 fewer to 3 more) ⊕⊕OO

Lowf

Due to risk of bias and imprecision
Rate of falls
 In hospitals or residential care

 Follow-up: median 6 (3–21) months

  > 50,054e (8)
RaR 0.74 (0.63 to 0.88) 672 per 1,000 person-years 497 per 1,000 person-years (423–591) 175 fewer falls per 1,000 person-years (249 fewer to 81 fewer) ⊕⊕⊕O

Moderateg

Due to risk of bias
 In community-dwelling older adults

 Follow-up: median 12 (12–24) months

 7,000 (5)
RaR 0.97 (0.93 to 1.00) 672 per 1,000 person-years 652 per 1,000 person-years (625–672) 20 fewer falls per 1,000 person-years (47 fewer to 0 fewer) ⊕⊕OO

Lowh

Due to risk of bias and imprecision
 In patients with mean age ≥ 80 years

 Follow-up: median 12 (3–12) months

 6,264 (7)
RaR 0.72 (0.61 to 0.86) 672 per 1,000 person-years 484 per 1,000 person-years

(410–578)
188 fewer falls per 1,000 person-years (262 fewer to 94 fewer) ⊕⊕⊕O

Moderatei

Due to risk of bias
 In patients with mean age between 65 and 80 years

 Follow-up: median 12 (6–24) months

 84,084 (6)
RaR 0.92 (0.84 to 1.01) 672 per 1,000 person-years 618 per 1,000 person-years (564–679) 54 fewer falls per 1,000 person-years (108 fewer to 7 more) ⊕⊕OO

Lowj

Due to risk of bias and imprecision
Rate of fall injuries
 In patients with mean age between 65 and 80 years

 Follow-up: median 16.5 (6–24) months

  > 50,979e (4)
RaR 0.80 (0.59 to 1.09) 164 per 1,000 person-years 131 per 1,000 person-years

(97–179)
33 fewer fall injuries per 1,000 person-years (67 fewer to 15 more) ⊕⊕OO

Lowk

Due to risk of bias and imprecision
 In patients with mean age ≥ 80 years

 Follow-up: median 9 (6–12) months

 3,445 (2)
RaR 1.29 (0.99 to 1.69) 164 per 1,000 person-years 212 per 1,000 person-years (162–277) 48 more fall injuries per 1,000 person-years (2 fewer to 113 more) ⊕OOO

Very lowl

Due to very serious risk of bias and imprecision

*Assuming a control group fall risk of 28.7%, a fall rate of 672 falls per 1,000 person-years, and a fall injury rate of 164 fall injuries per 1,000 person-years, based on data from Bergen et al. [62]. The risk in the intervention group is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CDS: clinical decision support; CI: confidence interval; HCPs: healthcare practitioners; OR: odds ratio; RaR: rate ratio.

Explanations:

aThe numbers of participating healthcare practitioners were not reported.

bNot estimable due to the use of different and incompletely reported effect measures across studies.

cVery serious risk of bias due to confounding, deviations from intended interventions, and selection of reported results.

dRisk of bias due to deviations from intended interventions.

eThe number of participants were not reported in all studies.

fRisk of bias due to the randomisation process, deviations from intended interventions, and measurement of the outcome. Imprecision due to the upper bound of the 95% confidence interval crossing the null effect.

gRisk of bias in the randomisation process and due to deviations from intended interventions.

hRisk of bias due to deviations from intended interventions. Imprecision due to the upper bound of the 95% confidence interval including the null effect.

iRisk of bias due to deviations from intended interventions and selection of reported results.

jRisk of bias due to the randomisation process, confounding, and deviations from intended interventions. Imprecision due to the upper bound of the 95% confidence interval crossing the null effect.

kRisk of bias due to confounding and deviations from intended interventions. Imprecision due to the upper bound of the 95% confidence interval crossing the null effect.

lVery serious risk of bias due to the randomisation process and confounding. Imprecision due to the lower bound of the 95% confidence interval crossing the null effect.

Adherence to recommended medication review and prescribing.

Five CRTs [23,39,70,72,87] and four IRPGTs [75,76,82,85] reported indicators of medication outcomes (Fig 2). The common outcome across these studies was the reviewing and prescribing of drugs that may increase fall risk. The median follow-up time was 9 months (range: 0–23 months). All nine results favoured the intervention (100%; 95% CI: 70% to 100%; p < 0.01). The certainty of evidence was moderate due to risk of bias. These findings suggest that CDS likely improves medication reviewing and prescribing outcomes in the context of fall prevention.

Patient outcomes

Fall risk.

Nineteen of the included studies reported outcome data on fall risk (proportion of participants who fell) and/or fall rate (number of falls per x person-years of follow-up), enabling meta-analyses of these outcomes. Ten studies were included in the meta-analysis on fall risk, with a median follow-up time of 9 months (range: 1–24 months) [23,27,72,74,76,79,80,82,86,87] (Fig 3). Of these studies, six were conducted in patients aged 65–80 years, three in patients aged 80 years or older, and one study did not report the age of patients. Furthermore, five studies were conducted in hospitals or residential care settings, while the other five focused on community-dwelling older adults. The overall estimated effect of CDS on fall risk was an odds ratio of 0.93 (95% CI: 0.85 to 1.01). Assuming a baseline fall risk of 28.7% [62], this 7% reduction in the odds of falling results in 14 fewer fallers per 1,000 older adults (95% CI: 32 fewer to 3 more) receiving the intervention compared with controls, during nine months of follow-up (Table 4). Heterogeneity was unimportant (I2 = 0%; p = 0.19). Visual inspection of the funnel plot showed no clear sign of small-study effects (S1 Fig). The Egger test suggested no evidence of small-study effects (p = 0.89). Additionally, the trim-and-fill analysis imputed no studies, and therefore made no difference in the effect estimate (S2 Fig). The certainty of the evidence was low due to risk of bias and imprecision. While CDS aimed at healthcare practitioners may influence fall risk, the evidence does not demonstrate a statistically significant effect, and uncertainty remains regarding its effectiveness.

Fig 3. Meta-analysis comparing CDS interventions with control on fall risk.

Fig 3

Red dashed line shows the point estimate for the meta-analysis overall. Risk of Bias legend: Circles: Green: Low risk of bias (RoB); Yellow: Some concerns for RoB; Red: High RoB; Orange: Serious RoB. 1a: Bias arising from the randomisation process. 1b: Bias arising from the timing of identification or recruitment of individual participants within clusters (for cluster-randomised only). 2: Bias due to deviations from intended interventions. 3: Bias due to missing outcome data. 4: Bias in measurement of the outcome. 5: Bias in selection of the reported result. O: Overall RoB judgement. * Non-randomised study. ROBINS-I was used to assess RoB.

Rate of falls.

Thirteen studies were included in the meta-analysis on fall rate [24,2628,38,69,74,75,79,8184] (Fig 4). Substantial heterogeneity was present in the effect estimate (I2 = 74%; p < 0.01). Subgroup analyses revealed statistically significant differences in fall rates when grouped by study setting (p < 0.01) and patients’ age (p < 0.01). The results are therefore presented separately by study setting and patients’ age.

Fig 4. Meta-analysis comparing CDS interventions with control on fall rate, subgroup analysis by study setting.

Fig 4

Red dashed line shows the point estimate for the meta-analysis overall. Risk of Bias legend: Circles: Green: Low risk of bias (RoB); Yellow: Some concerns for RoB; Red: High RoB; Orange: Serious RoB. 1a: Bias arising from the randomisation process. 1b: Bias arising from the timing of identification or recruitment of individual participants within clusters (for cluster-randomised only). 2: Bias due to deviations from intended interventions. 3: Bias due to missing outcome data. 4: Bias in measurement of the outcome. 5: Bias in selection of the reported result. O: Overall RoB judgement. * Non-randomised study. ROBINS-I was used to assess RoB.

Regarding subgroup analysis by study setting, the median follow-up time was 6 months (range: 3–21 months) for studies conducted in hospitals or residential care, and 12 months (range: 12–24 months) for studies on community-dwelling older adults. Among the eight studies conducted in hospitals or residential care, four included patients aged 80 years or older, and four included patients aged 65–80 years. Similarly, among the five studies focusing on community-dwelling older adults, three included patients aged 80 years or older, while two included patients aged 65–80 years. In hospitals or residential care, the overall estimated effect of CDS on fall rate was a rate ratio of 0.74 (95% CI: 0.63 to 0.88; I2 = 65%; p < 0.01). Assuming a baseline fall rate of 672 falls per 1,000 person-years [62], this 26% reduction in fall rate corresponds to 175 fewer falls per 1,000 person-years (95% CI: 249 fewer to 81 fewer) (Table 4). The certainty of the evidence was moderate due to risk of bias. These findings suggest that CDS aimed at healthcare practitioners likely reduces the rate of falls in hospitals and residential care settings.

For community-dwelling older adults, the overall estimated effect on fall rate was a rate ratio of 0.97 (95% CI: 0.93 to 1.00; I2 = 0%; p = 0.88). The certainty of the evidence was low due to risk of bias and imprecision. While CDS may influence fall rates in community-dwelling older adults, the effect is not statistically significant, and the certainty of the evidence is low.

Regarding the subgroup analysis by patients’ age, the median follow-up time was 12 months (range: 3–12 months) for studies involving patients with a mean age ≥ 80 years, and 12 months (range: 6–24 months) for studies of patients with a mean age between 65 and 80 years (S3 Fig). Among the six studies including patients aged 65–80 years, four were conducted in hospitals or residential care settings, while two focused on community-dwelling older adults. Similarly, among the seven studies involving patients aged 80 years or older, four were conducted in hospitals or residential care, while three focused on community-dwelling older adults. The overall estimated effect of CDS on fall rate among patients with a mean age of ≥ 80 years was a rate ratio of 0.72 (95% CI: 0.61 to 0.86; I2 = 46%; p = 0.09). Assuming a baseline fall rate of 672 falls per 1,000 person-years [62], this 28% reduction in fall rate corresponds to 188 fewer falls per 1,000 person-years (95% CI: 262 fewer to 94 fewer). The certainty of the evidence was moderate due to risk of bias. These findings suggest that CDS likely reduces the rate of falls among patients with a mean age of ≥ 80 years.

For patients with a mean age between 65 and 80 years, the overall estimated effect on fall rate was a rate ratio of 0.92 (95% CI: 0.84 to 1.01; I2 = 31%; p = 0.09). The certainty of the evidence was low due to risk of bias and imprecision. While CDS may influence fall rates in patients aged 65–80 years, the effect is not statistically significant, and the certainty of the evidence is low. Visual inspection of the funnel plot showed no clear sign of small-study effects (S4 Fig). The Egger test suggested no evidence of small-study effects (p = 0.99). Additionally, the trim-and-fill analysis imputed no studies and therefore made no difference in the effect estimate (S5 Fig). There was no statistically significant subgroup difference in fall rates when stratified by RoB (p = 0.47) (S6 Fig).

Rate of fall injuries.

Six studies were included in the meta-analysis on fall injury rate [24,26,28,77,79,81] (Fig 5). Substantial heterogeneity was present in the effect estimate (I2 = 71%, p = 0.03). Subgroup analyses revealed a statistically significant difference in fall injury rate between patients with a mean age of 65–80 years and patients with a mean age of 80 years or older (p = 0.02). The results are therefore presented separately by patients’ age. The median follow-up time was 16.5 months (range: 6–24 months) for studies including patients with a mean age of 65–80 years and 9 months (range: 6–12 months) for studies involving patients with a mean age of 80 years or older. The overall estimated effect of CDS in preventing fall injuries among patients aged 65–80 years was a rate ratio of 0.80 (95% CI: 0.59 to 1.09; I2 = 67%; p = 0.08), indicating a statistically non-significant result as the confidence interval crosses the null effect. Assuming a baseline fall injury rate of 164 fall injuries per 1,000 person-years [62], this 20% reduction in fall injury rate corresponds to 33 fewer fall injuries per 1,000 person-years (95% CI: 67 fewer to 15 more) in older adults receiving the intervention compared to controls (Table 4). The certainty of the evidence was low due to risk of bias and imprecision. While CDS may influence fall injury rates in patients aged 65–80 years, the effect is not statistically significant.

Fig 5. Meta-analysis comparing CDS interventions with control on fall injury rate, subgroup analysis by patients’ age.

Fig 5

Red dashed line shows the point estimate for the meta-analysis overall. Circles: Green: Low risk of bias (RoB); Yellow: Some concerns for RoB; Red: High RoB; Orange: Serious RoB. 1a: Bias arising from the randomisation process. 1b: Bias arising from the timing of identification or recruitment of individual participants within clusters (for cluster-randomised only). 2: Bias due to deviations from intended interventions. 3: Bias due to missing outcome data. 4: Bias in measurement of the outcome. 5: Bias in selection of the reported result. O: Overall RoB judgement. * Non-randomised study. ROBINS-I was used to assess RoB.

For patients with a mean age of 80 years or older, the overall estimated effect on fall injury rate was a rate ratio of 1.29 (95% CI: 0.99 to 1.69; I2 = 0%; p = 0.84). The certainty of the evidence was very low due to risk of bias and imprecision. We are very uncertain about the effect of CDS on fall injury rates in patients aged 80 years or older. There was no statistically significant subgroup difference in fall injury rates when stratified by RoB (p = 0.93) or study setting (p = 0.41). See S7 and S8 Figs for subgroup analyses on fall injury rate.

Mortality and hospitalisations

Five CRTs [7072,84,86] reported on mortality, while five IRPGTs [7476,82,83] and three CRTs [71,72,86] reported on hospital admissions. The sample sizes were small, the outcomes were rare, and no consistent patterns were observed in the direction of effect for either mortality or hospital admissions. For further details on individual study results, see S8 Table.

Certainty of the evidence

The certainty of the evidence was assessed for nine outcomes, with the results summarised in the GRADE evidence profile in S9 Table and Table 4.

Discussion

This systematic review summarised 25 studies (28 publications) investigating healthcare practitioners’ use of CDS in fall prevention and its effects on healthcare practitioner performance and patient outcomes. The interventions were delivered by nurses, physicians, physiotherapists, pharmacists, occupational therapists, and paramedics. Regarding healthcare practitioner performance, CDS may improve fall risk assessments and the provision of recommended interventions and likely improves medication review and prescribing. Regarding patient outcomes, CDS likely decreases the rate of falls in hospitals and residential care settings. CDS also likely reduces falls in patients aged 80 years or older. Furthermore, CDS may reduce fall rates in community-dwelling older adults. It also appears to reduce fall rates in patients aged 65–80 years; however, the effects in these subgroups may be small. CDS interventions likely reduce fall risk slightly and may reduce the rate of fall injuries in patients aged 65–80 years. Finally, while CDS may reduce fall injuries in adults aged 65–80 years, the effect on fall injuries in adults aged 80 years or older remains very uncertain.

Interventions

A common feature of all experimental interventions included in this review is that they delivered decision support to healthcare practitioners aiming to prevent falls in older adults. The control interventions were generally described only as consisting of usual care, with limited detail about the specific interventions, which varied depending on the setting and type of healthcare practitioner. Most experimental interventions utilised CDS to assist healthcare practitioners in conducting risk assessments and implementing preventive measures across multiple domains, such as gait and balance problems, environmental factors, and medications, rather than focusing on a single domain. Multifactorial fall prevention interventions have been shown effective in reducing falls [58], and the use of CDS to deliver such complex interventions may offer healthcare practitioners structure and guidance [89]. However, it is worth noting that, while most interventions provided CDS electronically, only 36% of the CDS tools automatically delivered recommendations to the healthcare practitioners. A systematic review previously found that automatically providing CDS recommendations, as opposed to requiring practitioners to access them on demand, may lead to large improvements in adherence to clinical guidelines [21].

Healthcare practitioner performance

Our findings align with those of previous systematic reviews, which have reported improvements in adherence to recommended practice [30,32] and medication outcomes [31]. Mebrahtu et al. [29] also found favourable effects on healthcare practitioner performance, including improvements in nurses’ adherence to hand disinfection guidance, insulin dosing, timely blood sampling, and documentation of care. Similarly, Kwan et al. [32] reported that CDS increased the proportion of patients receiving recommended care. Additionally, Yourman et al. [31] found that CDS improved medication outcomes in most cases. Although improvements were mostly moderate, these results demonstrate the diversity of clinical areas in which CDS may be beneficial.

Patient outcomes

Our meta-analyses suggested a possible reduction in fall risk with CDS, corresponding to an estimated range of 32 fewer to three more fallers per 1,000 older adults. They also indicated that CDS may reduce fall rates, with a reduction ranging from 20 to 188 fewer falls per 1,000 person-years. The studies included in the meta-analysis on fall risk represent a range of age groups and care settings, suggesting that the findings are broadly applicable to older adults at risk of falls. Several factors may explain the observed differences in the effects of CDS on fall risk versus fall rate. Dautzenberg et al. [11] proposed that the fall outcome may be more accurately measured using fall rate rather than fall risk. The ‘fall risk’ outcome counts the number of individuals who experience at least one fall, regardless of whether they fall multiple times, with each person contributing only one event. In contrast, the ‘rate of falls’ outcome captures each individual fall as a separate event. For example, a person who falls five times during the follow-up period would contribute five events to the ‘rate of falls’ outcome but only one event to the ‘fall risk’ outcome. If an intervention successfully prevents two of these five falls, it would lead to a reduced fall rate but not a reduced fall risk, as the individual would still be classified as having fallen. Consequently, the ‘fall risk’ outcome does not capture changes in the frequency of falls among older adults. It is possible that the interventions studied were more effective at reducing the frequency of falls among individuals with the highest fall risk, i.e., recurrent fallers, than among those who experienced only a single fall. A reduction in the frequency of falls among recurrent fallers would result in a greater reduction in fall rate compared to fall risk. In agreement with our findings, earlier systematic reviews [11,90] reported that multifactorial interventions were associated with a reduction in fall rate but had a smaller impact on fall risk.

The studies included in the meta-analyses on fall rate encompass a range of age groups and care settings, suggesting that the findings are broadly applicable to the entire study population. Several factors may explain the differences in fall rate reduction between settings, i.e., a 26% reduction in hospitals and residential care versus a 3% reduction in community-dwelling older adults. Older adults in hospitals and care homes are at high risk of falls [14], and interventions may be more effective in high-risk populations than in those at lower risk [91,92]. Even if the relative effects were similar, interventions directed at high-risk populations tend to show larger absolute effects than those directed at low- or moderate-risk populations. However, it is important to consider whether the relative effect itself varies across populations with different baseline risk levels, as this could further influence intervention outcomes. Furthermore, CDS tools may be more readily implemented in hospital and residential care settings than in primary care due to the greater complexity of these settings [93]. This may increase healthcare practitioners’ fidelity to intervention protocols, thereby increasing intervention effectiveness. Another contributing factor could be the differences in follow-up time across the included studies. The median follow-up time was six months for studies conducted in hospitals and residential care, compared to 12 months for studies involving community-dwelling older adults. The effectiveness of fall prevention interventions may dwindle as time passes [94], potentially because of patients discontinuing their engagement in fall prevention programmes, such as exercise regimens, after the study period [14].To reduce the risk of type I errors and avoid false positive results, we chose not to conduct a subgroup analysis by follow-up time. Moreover, while our results indicate a 26% reduction in fall rate in hospitals and residential care, the substantial heterogeneity (I2 = 65%) suggests that the observed effects likely vary across studies. This variability may be attributed to differences in study populations, settings, or intervention delivery. Despite this heterogeneity, CDS interventions targeting healthcare practitioners likely reduce fall rates in hospitals and residential care settings, although the effect size may depend on the context.

The certainty of the effects on fall injuries is low for patients aged 65–80 years and very low for patients aged 80 years or older, due to risk of bias and imprecision. The wide CIs for fall injury rates may be explained by the fact that fall injuries are relatively rare compared to falls [62]. Importantly, while the estimated effect of CDS on fall injuries among patients aged 80 years or older was a rate ratio of 1.29, the certainty of the evidence is very low. Notably, no studies outside the subgroup analysis on fall injury rate in this age group reported any negative effects attributed to the CDS interventions. Our findings are consistent with those of previous systematic reviews [29,31]. For instance, Yourman et al. found that while CDS may occasionally result in medication prescribing errors, it generally helps to reduce side-effects and improve patient safety [31].

When implementing innovations into clinical practice, both high-income countries (HIC) and low- and middle-income countries (LMIC) face barriers related to political, social, and cultural factors, as well as resource limitations and healthcare practitioner-related factors [95,96]. While the studies included in this review were conducted in HIC, LMIC face additional barriers, such as physical challenges like unreliable power supplies and poor internet connectivity, limited access to electronic health records and computers, and human resources constraints, including overburdened staff and insufficient formal training for healthcare workers [96]. These limitations in digital infrastructure could hinder the integration of CDS tools, which often rely on access to electronic health records and other digital systems [89]. To address these challenges, CDS systems need to be adaptable to LMIC contexts by incorporating offline functionality or offering paper-based versions. Additionally, CDS tools should be user-friendly to minimise the workload on already overburdened staff.

A notable aspect of this study is the absence of established MID values for fall risk, fall rate, and fall injury rate. We assessed certainty based on whether the true effect lies on the observed side of the null, using the null effect as the threshold. While some of the findings in this review suggest that the effects of CDS may be small, we did not determine what constitutes a minimal clinically important effect, as this often depends on the context and setting.

In HIC with robust healthcare infrastructure, even small reductions in fall risk or fall injuries may justify the use of CDS interventions. Conversely, in LMIC contexts, where resources such as computers, internet access, and trained personnel are limited, the threshold for what constitutes an important difference may be higher. In these settings, interventions with larger impacts may be prioritised to promote the best use of limited resources. Establishing context-specific thresholds for clinical importance could enable a more nuanced evaluation and better inform decisions on whether the implementation of CDS interventions is justified.

Implications

Given that many of the included studies targeted participants with an increased fall risk, such as previous fallers or those with specific risk factors, the findings of this review are likely most applicable to populations at higher risk of falls. Our estimates indicate that, on average, CDS interventions directed at healthcare practitioners may prevent 14 older adults per 1,000 from falling, assuming a baseline fall risk of 28.7%. Additionally, CDS interventions may prevent 175 falls per 1,000 person-years in hospitals and residential care, as well as 188 falls per 1,000 person-years in adults aged 80 years or older, assuming a baseline fall rate of 672 falls per 1,000 person-years. However, further research is needed to better understand the significant differences in fall rate reduction between hospitals or residential care settings and community-dwelling older adults. Future studies should aim to identify the factors that contribute to the greater effectiveness of interventions in hospitals and residential care and explore ways to adapt these strategies for community-dwelling older adults.

The findings of this review have important implications for the clinical implementation of CDS in different care settings. In hospital and residential care settings, where older adults often have a higher risk of falls and healthcare practitioners operate in more structured environments, CDS may be more readily implemented. The fall rate reductions observed in these settings suggest that CDS can support healthcare practitioners in conducting comprehensive fall risk assessments and delivering multifactorial interventions. In contrast, the implementation of CDS in community-based settings may face additional challenges, as these contexts often involve delivering services within older adults’ homes, which typically have less structure and access to digital infrastructure. These differences highlight the need to tailor CDS tools to the specific demands of each setting. For instance, in community-based settings, CDS tools that fit into existing workflows and provide automated decision-support could encourage greater adoption and adherence. Future research should investigate setting-specific determinants for the successful implementation of CDS, with a view to ensuring that tools are adaptable across diverse clinical environments.

This systematic review provides valuable insight to guide the implementation of CDS tools in fall prevention efforts among older adults. Directing interventions at high-risk populations may offer greater benefits than interventions aimed at low- or moderate-risk individuals. Additionally, CDS tools should be designed to automatically deliver on-screen decision support rather than relying on paper-based or on-demand systems [21]. Notably, only 36% of the CDS interventions included in this review met this criterion, highlighting an opportunity to further improve patient outcomes, adherence to recommended practice, and medication outcomes.

Strengths and limitations

To our knowledge, this is the first systematic review to provide a comprehensive overview of the effects of CDS used by healthcare practitioners in fall prevention among older adults. A major strength of this review is the use of a thorough and sensitive literature search strategy. Potential non-reporting biases, poor indexing, and other factors make it impossible to know whether all relevant studies were in fact identified [41]. We therefore searched the reference lists of included articles and relevant systematic reviews. Additionally, the funnel plots, along with Egger tests and trim-and-fill analyses, showed no evidence of publication bias for fall risk or fall rate outcomes. This indicates that we have likely included most relevant studies. Furthermore, outcomes related to healthcare practitioner performance were reported so varyingly among the studies that meta-analyses were not possible. We consider it a strength that we conducted vote-counting based on the direction of effect, rather than relying solely on textual descriptions of results [41]. Limitations of vote-counting include that the method provides no information on the magnitude of effects and does not account for differences in the relative sizes of the studies. However, vote-counting enables a statistical analysis of whether there is evidence of an intervention effect. Also, this method may be preferable to a narrative description, in which some results are privileged above others without appropriate justification [41]. Moreover, we performed meta-analyses on fall outcomes and applied the GRADE approach, making explicit judgements about the certainty of the evidence [97].

A limitation of this review is that verification of the collected data by a second reviewer was performed for only five of 25 included studies, raising concerns about potential errors during data collection. However, the selection of each result from each study was discussed and verified with the project statistician to ensure accuracy and consistency. Another limitation is the uncertainty surrounding the specific effects of different CDS tools. For example, while some tools delivered decision support to healthcare practitioners conducting multifactorial risk assessments and interventions [38,84], others focused exclusively on guided medication dosing [39,85]. This variation in tool types and use cases makes it difficult to evaluate the specific effects of different tools or to determine whether certain tools have any measurable impact at all. Furthermore, a limitation of the studies included in this review is that most results were judged as having a high or serious risk of bias. All results from the included non-randomised studies were judged to be at risk of bias due to confounding. The lack of randomisation increases the risk of unequal distribution of confounding factors between intervention groups, as group assignment may be influenced by knowledge of prognostic factors. Moreover, none of the included non-randomised studies employed analysis methods that adequately controlled for all important confounders, such as age, history of falls, sex, or gait and balance impairments. The direction and magnitude of this confounding remain unknown, making it difficult to determine whether the reported effect estimates are greater or lower than the true effect. For the randomised studies, the main concerns for risk of bias were related to deviations from intended interventions, such as crossover effects observed in Peterson et al. [85] and intervention contamination reported in Clemson et al. [69].

Conclusions

CDS likely improves the performance of healthcare practitioners in fall prevention for certain groups of older adults and in specific care settings. While CDS probably reduces falls and may lower fall injury rates, its effects appear to vary across different subgroups of older adults and care settings. This systematic review provides valuable insights into the role of CDS in supporting healthcare practitioners in fall prevention efforts among older adults. Prioritising resources and targeting interventions toward high-risk patients may yield the greatest impact in reducing falls. To maximise effectiveness, interventions should be sustained over time, and CDS tools should be designed to support improved adherence to recommended practice. Future research on fall injuries should aim to improve precision by increasing the number of participants and extending follow-up periods. In addition, meta-analyses of healthcare practitioner performance outcomes would become possible with standardised and detailed reporting of results. Finally, while the design of CDS tools may positively or negatively affect healthcare practitioners’ adherence to recommended practice, further research is needed to identify the specific design elements that contribute to successful outcomes in fall prevention.

Supporting information

S1 Table. PRISMA checklist.

(DOCX)

pone.0340025.s001.docx (33KB, docx)
S2 Table. Differences between protocol and review.

(DOCX)

pone.0340025.s002.docx (17KB, docx)
S3 Table. Electronic searches.

(DOCX)

pone.0340025.s003.docx (40.9KB, docx)
S4 Table. Excluded studies.

(XLSX)

pone.0340025.s004.xlsx (1.4MB, xlsx)
S5 Table. Description of interventions and funding sources.

(DOCX)

pone.0340025.s005.docx (142.6KB, docx)
S6 Table. Design factors of CDS.

(DOCX)

pone.0340025.s006.docx (113.8KB, docx)
S7 Table. Risk of bias.

(PDF)

pone.0340025.s007.pdf (824.4KB, pdf)
S8 Table. Individual study results.

(DOCX)

pone.0340025.s008.docx (53KB, docx)
S9 Table. GRADE evidence profile.

(DOCX)

pone.0340025.s009.docx (47.3KB, docx)
S1 Appendix. Data used for analyses of healthcare practitioner performance outcomes.

(XLSX)

pone.0340025.s010.xlsx (17.6KB, xlsx)
S2 Appendix. Data used for meta-analyses.

(XLSX)

pone.0340025.s011.xlsx (46.7KB, xlsx)
S3 Appendix. Extracted data.

(CSV)

pone.0340025.s012.csv (503.9KB, csv)
S1 Fig. Funnell plot of comparison: CDS interventions vs control on fall risk.

(PNG)

pone.0340025.s013.png (141KB, png)
S2 Fig. Trim-and-fill analysis of comparison: CDS interventions vs control on fall risk.

(PNG)

pone.0340025.s014.png (106.4KB, png)
S3 Fig. Meta-analysis comparing CDS interventions with control on fall rate, subgroup analysis by patients’ age.

(PNG)

pone.0340025.s015.png (310.9KB, png)
S4 Fig. Funnel plot of comparison: CDS interventions vs control on fall rate.

(PNG)

pone.0340025.s016.png (70.2KB, png)
S5 Fig. Trim-and-fill analysis of comparison: CDS interventions vs control on fall rate.

(PNG)

pone.0340025.s017.png (87.5KB, png)
S6 Fig. Meta-analysis comparing CDS interventions with control on fall rate, subgroup analysis by risk of bias.

(PNG)

pone.0340025.s018.png (335KB, png)
S7 Fig. Meta-analysis comparing CDS interventions with control on fall injury rate, subgroup analysis by risk of bias.

(PNG)

pone.0340025.s019.png (298.1KB, png)
S8 Fig. Meta-analysis comparing CDS interventions with control on fall injury rate, subgroup analysis by study setting.

(PNG)

pone.0340025.s020.png (302.8KB, png)

Acknowledgments

The authors are grateful to help provided by Elisabeth Karlsen and Kari Kalland (OsloMet) for electronic database searches.

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

This study was funded by the Research Council of Norway under grant number 301996, awarded to OsloMet – Oslo Metropolitan University, Faculty of Health Sciences. The funder did not play any role in the study design, data collection and and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Elias Filho J, Borel WP, Diz JBM, Barbosa AWC, Britto RR, Felício DC. Prevalence of falls and associated factors in community-dwelling older Brazilians: a systematic review and meta-analysis. Cad Saude Publica. 2019;35(8):e00115718. doi: 10.1590/0102-311X00115718 [DOI] [PubMed] [Google Scholar]
  • 2.James SL, Lucchesi LR, Bisignano C, Castle CD, Dingels ZV, Fox JT, et al. The global burden of falls: global, regional and national estimates of morbidity and mortality from the Global Burden of Disease Study 2017. Inj Prev. 2020;26(Supp 1):i3–11. doi: 10.1136/injuryprev-2019-043286 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Haagsma JA, Olij BF, Majdan M, van Beeck EF, Vos T, Castle CD, et al. Falls in older aged adults in 22 European countries: incidence, mortality and burden of disease from 1990 to 2017. Inj Prev. 2020;26(Supp 1):i67–74. doi: 10.1136/injuryprev-2019-043347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Davis JC, Robertson MC, Ashe MC, Liu-Ambrose T, Khan KM, Marra CA. International comparison of cost of falls in older adults living in the community: a systematic review. Osteoporos Int. 2010;21(8):1295–306. doi: 10.1007/s00198-009-1162-0 [DOI] [PubMed] [Google Scholar]
  • 5.Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C. Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc. 2018;66(4):693–8. doi: 10.1111/jgs.15304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Heinrich S, Rapp K, Rissmann U, Becker C, König H-H. Cost of falls in old age: a systematic review. Osteoporos Int. 2010;21(6):891–902. doi: 10.1007/s00198-009-1100-1 [DOI] [PubMed] [Google Scholar]
  • 7.Li Y, Hou L, Zhao H, Xie R, Yi Y, Ding X. Risk factors for falls among community-dwelling older adults: a systematic review and meta-analysis. Front Med (Lausanne). 2023;9:1019094. doi: 10.3389/fmed.2022.1019094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Shao L, Shi Y, Xie X-Y, Wang Z, Wang Z-A, Zhang J-E. Incidence and risk factors of falls among older people in nursing homes: systematic review and meta-analysis. J Am Med Dir Assoc. 2023;24(11):1708–17. doi: 10.1016/j.jamda.2023.06.002 [DOI] [PubMed] [Google Scholar]
  • 9.Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;2012(9):CD007146. doi: 10.1002/14651858.CD007146.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Olij BF, Ophuis RH, Polinder S, van Beeck EF, Burdorf A, Panneman MJM, et al. Economic evaluations of falls prevention programs for older adults: a systematic review. J Am Geriatr Soc. 2018;66(11):2197–204. doi: 10.1111/jgs.15578 [DOI] [PubMed] [Google Scholar]
  • 11.Dautzenberg L, Beglinger S, Tsokani S, Zevgiti S, Raijmann RCMA, Rodondi N, et al. Interventions for preventing falls and fall-related fractures in community-dwelling older adults: a systematic review and network meta-analysis. J Am Geriatr Soc. 2021;69(10):2973–84. doi: 10.1111/jgs.17375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Meekes WM, Korevaar JC, Leemrijse CJ, van de Goor IA. Practical and validated tool to assess falls risk in the primary care setting: a systematic review. BMJ Open. 2021;11(9):e045431. doi: 10.1136/bmjopen-2020-045431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stevens JA, Ballesteros MF, Mack KA, Rudd RA, DeCaro E, Adler G. Gender differences in seeking care for falls in the aged Medicare population. Am J Prev Med. 2012;43(1):59–62. doi: 10.1016/j.amepre.2012.03.008 [DOI] [PubMed] [Google Scholar]
  • 14.Montero-Odasso M, van der Velde N, Martin FC, Petrovic M, Tan MP, Ryg J, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing. 2022;51(9):afac205. doi: 10.1093/ageing/afac205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Markle-Reid MF, Dykeman CS, Reimer HD, Boratto LJ, Goodall CE, McGugan JL. Engaging community organizations in falls prevention for older adults: moving from research to action. Can J Public Health. 2015;106(4):e189-96. doi: 10.17269/cjph.106.4776 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Olij BF, Erasmus V, Kuiper JI, van Zoest F, van Beeck EF, Polinder S. Falls prevention activities among community-dwelling elderly in the Netherlands: a Delphi study. Injury. 2017;48(9):2017–21. doi: 10.1016/j.injury.2017.06.022 [DOI] [PubMed] [Google Scholar]
  • 17.Leysens G, Vlaeyen E, Vanaken D, Janssens E, Dejaeger E, Cambier D, et al. Het toepassen van valpreventiemaatregelen bij thuiswonende ouderen: een survey onderzoek in Vlaanderen [The use of fall prevention strategies in home care: a survey in Flanders]. Tijdschr Gerontol Geriatr. 2017;48:121–33. doi: 10.1007/s12439-017-0215-7 [DOI] [PubMed] [Google Scholar]
  • 18.Moreland B, Kakara R, Henry A. Trends in nonfatal falls and fall-related injuries among adults aged ≥65 years - United States, 2012-2018. MMWR Morb Mortal Wkly Rep. 2020;69(27):875–81. doi: 10.15585/mmwr.mm6927a5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shaver AL, Clark CM, Hejna M, Feuerstein S, Wahler RG Jr, Jacobs DM. Trends in fall-related mortality and fall risk increasing drugs among older individuals in the United States,1999-2017. Pharmacoepidemiol Drug Saf. 2021;30(8):1049–56. doi: 10.1002/pds.5201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fretheim A, Flottorp S, Oxman A. Effekt av tiltak for implementering av kliniske retningslinjer. Rapport fra Kunnskapssenteret nr. 10-2015. Oversikt over systematiske oversikter [Effect of interventions for implementing clinical practice guidelines]. Oslo; 2015. [Google Scholar]
  • 21.Van de Velde S, Heselmans A, Delvaux N, Brandt L, Marco-Ruiz L, Spitaels D, et al. A systematic review of trials evaluating success factors of interventions with computerised clinical decision support. Implement Sci. 2018;13(1):114. doi: 10.1186/s13012-018-0790-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wasylewicz ATM, Scheepers-Hoeks AMJW. Clinical Decision Support Systems. In: Kubben P, Dumontier M, Dekker A, editors. Fundamentals of Clinical Data Science. Cham (CH): Springer. 2018. p. 153–69. doi: 10.1007/978-3-319-99713-1_11 [DOI] [PubMed] [Google Scholar]
  • 23.Blalock SJ, Ferreri SP, Renfro CP, Robinson JM, Farley JF, Ray N, et al. Impact of STEADI-Rx: a community pharmacy-based fall prevention intervention. J Am Geriatr Soc. 2020;68(8):1778–86. doi: 10.1111/jgs.16459 [DOI] [PubMed] [Google Scholar]
  • 24.Dykes PC, Carroll DL, Hurley A, Lipsitz S, Benoit A, Chang F, et al. Fall prevention in acute care hospitals: a randomized trial. JAMA. 2010;304(17):1912–8. doi: 10.1001/jama.2010.1567 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Carroll DL, Dykes PC, Hurley AC. An electronic fall prevention toolkit: effect on documentation quality. Nurs Res. 2012;61(4):309–13. doi: 10.1097/NNR.0b013e31825569de [DOI] [PubMed] [Google Scholar]
  • 26.Dykes PC, Burns Z, Adelman J, Benneyan J, Bogaisky M, Carter E, et al. Evaluation of a patient-centered fall-prevention tool kit to reduce falls and injuries: a nonrandomized controlled trial. JAMA Netw Open. 2020;3(11):e2025889. doi: 10.1001/jamanetworkopen.2020.25889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Aizen E, Lutsyk G, Wainer L, Carmeli S. Effectiveness of individualized fall prevention program in geriatric rehabilitation hospital setting: a cluster randomized trial. Aging Clin Exp Res. 2015;27(5):681–8. doi: 10.1007/s40520-015-0330-7 [DOI] [PubMed] [Google Scholar]
  • 28.Barker AL, Morello RT, Wolfe R, Brand CA, Haines TP, Hill KD, et al. 6-PACK programme to decrease fall injuries in acute hospitals: cluster randomised controlled trial. BMJ. 2016;352:h6781. doi: 10.1136/bmj.h6781 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mebrahtu TF, Skyrme S, Randell R, Keenan A-M, Bloor K, Yang H, et al. Effects of computerised clinical decision support systems (CDSS) on nursing and allied health professional performance and patient outcomes: a systematic review of experimental and observational studies. BMJ Open. 2021;11(12):e053886. doi: 10.1136/bmjopen-2021-053886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Damoiseaux-Volman BA, van der Velde N, Ruige SG, Romijn JA, Abu-Hanna A, Medlock S. Effect of interventions with a clinical decision support system for hospitalized older patients: systematic review mapping implementation and design factors. JMIR Med Inform. 2021;9(7):e28023. doi: 10.2196/28023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yourman L, Concato J, Agostini JV. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother. 2008;6(2):119–29. doi: 10.1016/j.amjopharm.2008.06.001 [DOI] [PubMed] [Google Scholar]
  • 32.Kwan JL, Lo L, Ferguson J, Goldberg H, Diaz-Martinez JP, Tomlinson G, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ. 2020;370:m3216. doi: 10.1136/bmj.m3216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Moja L, Kwag KH, Lytras T, Bertizzolo L, Brandt L, Pecoraro V, et al. Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis. Am J Public Health. 2014;104(12):e12–22. doi: 10.2105/AJPH.2014.302164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Garg AX, Adhikari NKJ, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293(10):1223–38. doi: 10.1001/jama.293.10.1223 [DOI] [PubMed] [Google Scholar]
  • 35.Jaspers MWM, Smeulers M, Vermeulen H, Peute LW. Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings. J Am Med Inform Assoc. 2011;18(3):327–34. doi: 10.1136/amiajnl-2011-000094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Taheri Moghadam S, Sadoughi F, Velayati F, Ehsanzadeh SJ, Poursharif S. The effects of clinical decision support system for prescribing medication on patient outcomes and physician practice performance: a systematic review and meta-analysis. BMC Med Inform Decis Mak. 2021;21(1):98. doi: 10.1186/s12911-020-01376-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Shahmoradi L, Safdari R, Ahmadi H, Zahmatkeshan M. Clinical decision support systems-based interventions to improve medication outcomes: a systematic literature review on features and effects. Med J Islam Repub Iran. 2021;35:27. doi: 10.47176/mjiri.35.27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Elley CR, Robertson MC, Garrett S, Kerse NM, McKinlay E, Lawton B, et al. Effectiveness of a falls-and-fracture nurse coordinator to reduce falls: a randomized, controlled trial of at-risk older adults. J Am Geriatr Soc. 2008;56(8):1383–9. doi: 10.1111/j.1532-5415.2008.01802.x [DOI] [PubMed] [Google Scholar]
  • 39.Tamblyn R, Eguale T, Buckeridge DL, Huang A, Hanley J, Reidel K, et al. The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial. J Am Med Inform Assoc. 2012;19(4):635–43. doi: 10.1136/amiajnl-2011-000609 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. doi: 10.1136/bmj.g7647 [DOI] [PubMed] [Google Scholar]
  • 41.Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. [Google Scholar]
  • 42.EPOC resources for review authors. [cited 22 Nov 2020]. Available from: https://epoc.cochrane.org/resources/epoc-resources-review-authors [Google Scholar]
  • 43.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Covidence Systematic Review Tool. In: Covidence [Internet]. [cited 17 May 2025]. Available from: https://www.covidence.org/ [Google Scholar]
  • 45.Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, et al. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40(5):1199–208. doi: 10.1007/s11096-018-0696-7 [DOI] [PubMed] [Google Scholar]
  • 46.El-Khoury F, Cassou B, Charles M-A, Dargent-Molina P. The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults. Br J Sports Med. 2015;49(20):1348–1348. doi: 10.1136/bmj.f6234 [DOI] [PubMed] [Google Scholar]
  • 47.Seppala LJ, van de Glind EMM, Daams JG, Ploegmakers KJ, de Vries M, Wermelink AMAT, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. others. J Am Med Dir Assoc. 2018;19(4):372.e1–372.e8. doi: 10.1016/j.jamda.2017.12.099 [DOI] [PubMed] [Google Scholar]
  • 48.Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. doi: 10.1136/bmj.g1687 [DOI] [PubMed] [Google Scholar]
  • 49.Lewin S, Hendry M, Chandler J, Oxman AD, Michie S, Shepperd S, et al. Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR). BMC Med Res Methodol. 2017;17(1):76. doi: 10.1186/s12874-017-0349-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Lamb SE, Becker C, Gillespie LD, Smith JL, Finnegan S, Potter R, et al. Reporting of complex interventions in clinical trials: development of a taxonomy to classify and describe fall-prevention interventions. Trials. 2011;12:125. doi: 10.1186/1745-6215-12-125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Van de Velde S, Kunnamo I, Roshanov P, Kortteisto T, Aertgeerts B, Vandvik PO, et al. The GUIDES checklist: development of a tool to improve the successful use of guideline-based computerised clinical decision support. Implement Sci. 2018;13(1):86. doi: 10.1186/s13012-018-0772-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Medlock S, Wyatt JC, Patel VL, Shortliffe EH, Abu-Hanna A. Modeling information flows in clinical decision support: key insights for enhancing system effectiveness. J Am Med Inform Assoc. 2016;23(5):1001–6. doi: 10.1093/jamia/ocv177 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898 [DOI] [PubMed] [Google Scholar]
  • 54.Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Sterne J, Hernán M, McAleenan A, Reeves B, Higgins J. Chapter 25: Assessing risk of bias in a non-randomized study. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. http://www.training.cochrane.org/handbook [Google Scholar]
  • 56.Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. doi: 10.1136/bmj.l6890 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.McKenzie J, Brennan S. Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. http://www.training.cochrane.org/handbook [Google Scholar]
  • 58.Tricco AC, Thomas SM, Veroniki AA, Hamid JS, Cogo E, Strifler L, et al. Comparisons of interventions for preventing falls in older adults: a systematic review and meta-analysis. JAMA. 2017;318(17):1687–99. doi: 10.1001/jama.2017.15006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Deeks JJ, Higgins JP, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. www.training.cochrane.org/handbook [Google Scholar]
  • 60.StataCorp. Stata Statistical Software: Release 18. College Station, TX: StataCorp; 2023. [Google Scholar]
  • 61.Higgins J, Li T, Deeks J. Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. http://www.training.cochrane.org/handbook [Google Scholar]
  • 62.Bergen G, Stevens MR, Burns ER. Falls and fall injuries among adults aged ≥65 years - United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(37):993–8. doi: 10.15585/mmwr.mm6537a2 [DOI] [PubMed] [Google Scholar]
  • 63.Guyatt G, Zeng L, Brignardello-Petersen R, Prasad M, De Beer H, Murad MH, et al. Core GRADE 2: choosing the target of certainty rating and assessing imprecision. BMJ. 2025;389:e081904. doi: 10.1136/bmj-2024-081904 [DOI] [PubMed] [Google Scholar]
  • 64.Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34. doi: 10.1136/bmj.315.7109.629 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4–13. doi: 10.1016/j.jclinepi.2017.05.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Zeng L, Brignardello-Petersen R, Hultcrantz M, Mustafa RA, Murad MH, Iorio A, et al. GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol. 2022;150:216–24. doi: 10.1016/j.jclinepi.2022.07.014 [DOI] [PubMed] [Google Scholar]
  • 67.Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126–35. doi: 10.1016/j.jclinepi.2019.10.014 [DOI] [PubMed] [Google Scholar]
  • 68.Guyatt G, Yao L, Murad MH, Hultcrantz M, Agoritsas T, De Beer H, et al. Core GRADE 6: presenting the evidence in summary of findings tables. BMJ. 2025;389:e083866. doi: 10.1136/bmj-2024-083866 [DOI] [PubMed] [Google Scholar]
  • 69.Clemson L, Mackenzie L, Lovarini M, Roberts C, Poulos R, Sherrington C, et al. Integrated solutions for sustainable fall prevention in primary care: a pragmatic hybrid-type 2 mixed methods implementation and effectiveness study. Front Public Health. 2024;12:1446525. doi: 10.3389/fpubh.2024.1446525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Phelan EA, Williamson BD, Balderson BH, Cook AJ, Piccorelli AV, Fujii MM, et al. Reducing central nervous system-active medications to prevent falls and injuries among older adults: a cluster randomized clinical trial. JAMA Netw Open. 2024;7(7):e2424234. doi: 10.1001/jamanetworkopen.2024.24234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Bhasin S, Gill TM, Reuben DB, Latham NK, Ganz DA, Greene EJ, et al. A randomized trial of a multifactorial strategy to prevent serious fall injuries. N Engl J Med. 2020;383(2):129–40. doi: 10.1056/NEJMoa2002183 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Blum MR, Sallevelt BTGM, Spinewine A, O’Mahony D, Moutzouri E, Feller M, et al. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ. 2021;374:n1585. doi: 10.1136/bmj.n1585 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Byrne CM. Impact of prospective computerized clinical decision support information and targeted assistance on nursing home resident outcomes. University of Albany, State University of New York. 2005. Available from: https://www.proquest.com/openview/59a276fe7e8913563fcd2bb9b487d19d/1?pq-origsite=gscholar&cbl=18750&diss=y [Google Scholar]
  • 74.Ferrer A, Formiga F, Sanz H, de Vries OJ, Badia T, Pujol R, et al. Multifactorial assessment and targeted intervention to reduce falls among the oldest-old: a randomized controlled trial. Clin Interv Aging. 2014;9:383–93. doi: 10.2147/CIA.S57580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62(9):1658–65. doi: 10.1111/jgs.12993 [DOI] [PubMed] [Google Scholar]
  • 76.Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–54. doi: 10.1038/clpt.2011.44 [DOI] [PubMed] [Google Scholar]
  • 77.Ganz DA, Kim S-B, Zingmond DS, Ramirez KD, Roth CP, Jennings LA, et al. Effect of a falls quality improvement program on serious fall-related injuries. J Am Geriatr Soc. 2015;63(1):63–70. doi: 10.1111/jgs.13154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Wenger NS, Roth CP, Hall WJ, Ganz DA, Snow V, Byrkit J, et al. Practice redesign to improve care for falls and urinary incontinence: primary care intervention for older patients. Arch Intern Med. 2010;170(19):1765–72. doi: 10.1001/archinternmed.2010.387 [DOI] [PubMed] [Google Scholar]
  • 79.Ganz DA, Yuan AH, Greene EJ, Latham NK, Araujo K, Siu AL, et al. Effect of the STRIDE fall injury prevention intervention on falls, fall injuries, and health-related quality of life. J Am Geriatr Soc. 2022;70(11):3221–9. doi: 10.1111/jgs.17964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Groshaus H, Boscan A, Khandwala F, Holroyd-Leduc J. Use of clinical decision support to improve the quality of care provided to older hospitalized patients. Appl Clin Inform. 2012;3(1):94–102. doi: 10.4338/ACI-2011-08-RA-0047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Healey F, Monro A, Cockram A, Adams V, Heseltine D. Using targeted risk factor reduction to prevent falls in older in-patients: a randomised controlled trial. Age Ageing. 2004;33(4):390–5. doi: 10.1093/ageing/afh130 [DOI] [PubMed] [Google Scholar]
  • 82.Lightbody E, Watkins C, Leathley M, Sharma A, Lye M. Evaluation of a nurse-led falls prevention programme versus usual care: a randomized controlled trial. Age Ageing. 2002;31(3):203–10. doi: 10.1093/ageing/31.3.203 [DOI] [PubMed] [Google Scholar]
  • 83.Mahoney JE, Shea TA, Przybelski R, Jaros L, Gangnon R, Cech S, et al. Kenosha County falls prevention study: a randomized, controlled trial of an intermediate-intensity, community-based multifactorial falls intervention. J Am Geriatr Soc. 2007;55(4):489–98. doi: 10.1111/j.1532-5415.2007.01144.x [DOI] [PubMed] [Google Scholar]
  • 84.Logan PA, Horne JC, Gladman JRF, Gordon AL, Sach T, Clark A, et al. Multifactorial falls prevention programme compared with usual care in UK care homes for older people: multicentre cluster randomised controlled trial with economic evaluation. BMJ. 2021;375:e066991. doi: 10.1136/bmj-2021-066991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Peterson JF, Rosenbaum BP, Waitman LR, Habermann R, Powers J, Harrell D, et al. Physicians’ response to guided geriatric dosing: initial results from a randomized trial. Stud Health Technol Inform. 2007;129(Pt 2):1037–40. [PubMed] [Google Scholar]
  • 86.Snooks HA, Carter B, Dale J, Foster T, Humphreys I, Logan PA, et al. Support and Assessment for Fall Emergency Referrals (SAFER 1): cluster randomised trial of computerised clinical decision support for paramedics. PLoS One. 2014;9(9):e106436. doi: 10.1371/journal.pone.0106436 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Weber V, White A, McIlvried R. An electronic medical record (EMR)-based intervention to reduce polypharmacy and falls in an ambulatory rural elderly population. J Gen Intern Med. 2008;23(4):399–404. doi: 10.1007/s11606-007-0482-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Wenger NS, Roth CP, Shekelle PG, Young RT, Solomon DH, Kamberg CJ, et al. A practice-based intervention to improve primary care for falls, urinary incontinence, and dementia. J Am Geriatr Soc. 2009;57(3):547–55. doi: 10.1111/j.1532-5415.2008.02128.x [DOI] [PubMed] [Google Scholar]
  • 89.Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;3:17. doi: 10.1038/s41746-020-0221-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Hopewell S, Adedire O, Copsey BJ, Boniface GJ, Sherrington C, Clemson L, et al. Multifactorial and multiple component interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2018;7(7):CD012221. doi: 10.1002/14651858.CD012221.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Wang H, Boissel J-P, Nony P. Revisiting the relationship between baseline risk and risk under treatment. Emerg Themes Epidemiol. 2009;6:1. doi: 10.1186/1742-7622-6-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Ho KM. Importance of the baseline risk in determining sample size and power of a randomized controlled trial. J Emerg Crit Care Med. 2018;2:70–70. doi: 10.21037/jeccm.2018.08.06 [DOI] [Google Scholar]
  • 93.Goodwin V, Jones-Hughes T, Thompson-Coon J, Boddy K, Stein K. Implementing the evidence for preventing falls among community-dwelling older people: a systematic review. J Safety Res. 2011;42(6):443–51. doi: 10.1016/j.jsr.2011.07.008 [DOI] [PubMed] [Google Scholar]
  • 94.Finnegan S, Seers K, Bruce J. Long-term follow-up of exercise interventions aimed at preventing falls in older people living in the community: a systematic review and meta-analysis. Physiotherapy. 2019;105(2):187–99. doi: 10.1016/j.physio.2018.09.002 [DOI] [PubMed] [Google Scholar]
  • 95.Wang T, Tan J-YB, Liu X-L, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ Open. 2023;13(1):e062158. doi: 10.1136/bmjopen-2022-062158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Leonard E, de Kock I, Bam W. Barriers and facilitators to implementing evidence-based health innovations in low- and middle-income countries: a systematic literature review. Eval Program Plann. 2020;82:101832. doi: 10.1016/j.evalprogplan.2020.101832 [DOI] [PubMed] [Google Scholar]
  • 97.Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE Handbook: Introduction to GRADE Handbook. 2013. https://gdt.gradepro.org/app/handbook/handbook.html [Google Scholar]

Decision Letter 0

Nishant Jaiswal

7 May 2025

Dear Dr. Solli,

Please submit your revised manuscript by Jun 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Nishant Premnath Jaiswal, MBBS, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have contradictory statements about the literature search in your manuscript. Please can you remove the list of languages the studies reported are in as this suggests that a language restriction was imposed.

3. As required by our policy on Data Availability, please ensure your manuscript or supplementary information includes the following:

A numbered table of all studies identified in the literature search, including those that were excluded from the analyses. 

For every excluded study, the table should list the reason(s) for exclusion. 

If any of the included studies are unpublished, include a link (URL) to the primary source or detailed information about how the content can be accessed.

A table of all data extracted from the primary research sources for the systematic review and/or meta-analysis. The table must include the following information for each study:

Name of data extractors and date of data extraction

Confirmation that the study was eligible to be included in the review. 

All data extracted from each study for the reported systematic review and/or meta-analysis that would be needed to replicate your analyses.

If data or supporting information were obtained from another source (e.g. correspondence with the author of the original research article), please provide the source of data and dates on which the data/information were obtained by your research group.

If applicable for your analysis, a table showing the completed risk of bias and quality/certainty assessments for each study or outcome.  Please ensure this is provided for each domain or parameter assessed. For example, if you used the Cochrane risk-of-bias tool for randomized trials, provide answers to each of the signalling questions for each study. If you used GRADE to assess certainty of evidence, provide judgements about each of the quality of evidence factor. This should be provided for each outcome. 

An explanation of how missing data were handled.

This information can be included in the main text, supplementary information, or relevant data repository. Please note that providing these underlying data is a requirement for publication in this journal, and if these data are not provided your manuscript might be rejected. 

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Abstract:

Please clarify the statement that the effect on medications was uncertain. Methods did not describe a search for effects on any medication. Page 10 of the manuscript describes monitoring use of "fall-risk increasing drugs”. It may help to mention this in the abstract so readers know what type of medications were measured/reported.

The statement, “CDS interventions may reduce fall injury rate in older adults aged between 65 and 80 years (RaR 0.80; 95% CI 0.59, 1.09)” does not seem accurate because the confidence interval crosses the 1.0 value. Please consider restating this

If I understand the data correctly, it may be more accurate to change the last sentence of the Abstract to: “but the evidence on fall injury rate in community-dwelling patients aged 80 years or older was very uncertain.” In other words, CDS use worked well in hospitals and residential care, but the effect was not statistically significant in community dwelling patients. This is such an important observation that it needs to be clear here and in the Conclusion of the Abstract on Page 3.

Manuscript (MS)

Please check grammar throughout the MS. For example, Page 4, Introduction line 2 “leading” should be “leads”. This is an important, well-done study, potentially affecting important clinical and health economic outcomes. Grammatical errors distract from its credibility and potential clinical use.

I do not have time to address every grammatical error. This needs review by a good editor.

Reviewer #2: This systematic review and meta-analysis is an important contribution to the literature on fall prevention in older adults using CDS interventions.

The methodology is rigorous, and the conclusions are generally well-supported by the evidence.

Strengths include the comprehensive search, transparent methods, proper use of meta-analytic techniques, subgroup analyses, and the application of GRADE.

Minor points for improvement:

Discussion clarity: Some explanations regarding the difference between fall rate and fall risk outcomes could be streamlined to enhance reader understanding.

Graphical presentation: Figures could be slightly improved to enhance readability (e.g., legends and risk of bias charts could be made larger for clarity).

No ethical concerns were identified.

No concerns regarding plagiarism, redundant publication, or data fabrication were noted.

Recommendation:

Minor revision (language polishing in Discussion and minor graphical improvements).

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Laura Bolton, PhD

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

PLoS One. 2026 Jan 12;21(1):e0340025. doi: 10.1371/journal.pone.0340025.r002

Author response to Decision Letter 1


9 Jun 2025

Response to Reviewers

Dear Dr. Nishant Premnath Jaiswal

Thank you for giving us the opportunity to submit a revised draft of our manuscript titled "Effectiveness of clinical decision support in fall prevention among older adults: a systematic review and meta-analysis" to PLOS ONE. We appreciate the time and effort you and the reviewers have invested in providing valuable feedback on our manuscript. We have carefully considered the comments and have revised the manuscript to address the suggestions provided.

All authors have reviewed and approved the submission of the revised manuscript. The manuscript has not been published and is not being considered for publication elsewhere, in whole or in part, in any language. We hope you will now be able to accept the article for publication in your journal.

Thank you for your consideration.

Yours sincerely

Rune Solli on behalf of the authors

Response to the Academic Editor

Comment 1:

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response 1:

Thank you for your feedback. We have made changes to the manuscript to meet PLOS ONE’s style requirements, including the following:

• We corrected an error on the title page; please refer to page 1, line 10 for details. We have also updated affiliation 5 and removed affiliation 6 for a co-author. Affiliation 6 was removed because this co-author is no longer associated with that institution. Please see page 1, lines 5, 15, and 16.

• Headings:

o We used level 1 heading for all major sections of the manuscript, level 2 heading for sub-sections of major sections, and level 3 heading for sub-sections within level 2 headings.

o We used bold type, sentence case, and the correct font size for the different heading levels.

• Figures and tables:

o We made corrections to the table and figure titles and legends.

o We reformatted Table 4 to a figure, more specifically to Figure 2, because it contains graphics.

o We renamed Fig 2 as Fig 3, Fig 3 as Fig 4, and Fig 4 as Fig 5.

o We reformatted the manuscript’s figure files as .tif files.

o We renamed Figure file names to Fig1, Fig2, Fig3, etc.

o We changed the resolution of the manuscript Figs to 300 dpi.

o We moved the tables and figures to appear directly after the paragraph where they are first cited.

• Supporting information:

o Please see our response to Comment 3 for details on the changes made to the supporting information.

• References:

o We changed reference style to comply with PLOS ONE’s guidelines. For more information on the changes made to the reference list, please refer to our response to Comment 4.

Comment 2:

We note that you have contradictory statements about the literature search in your manuscript. Please can you remove the list of languages the studies reported are in as this suggests that a language restriction was imposed.

Response 2:

Thank you for pointing this out. We have removed the list of languages the studies are reported in. Please see page 7, lines 154-155.

Comment 3:

As required by our policy on Data Availability, please ensure your manuscript or supplementary information includes the following:

A numbered table of all studies identified in the literature search, including those that were excluded from the analyses.

For every excluded study, the table should list the reason(s) for exclusion.

If any of the included studies are unpublished, include a link (URL) to the primary source or detailed information about how the content can be accessed.

A table of all data extracted from the primary research sources for the systematic review and/or meta-analysis. The table must include the following information for each study:

Name of data extractors and date of data extraction

Confirmation that the study was eligible to be included in the review.

All data extracted from each study for the reported systematic review and/or meta-analysis that would be needed to replicate your analyses.

If data or supporting information were obtained from another source (e.g. correspondence with the author of the original research article), please provide the source of data and dates on which the data/information were obtained by your research group.

If applicable for your analysis, a table showing the completed risk of bias and quality/certainty assessments for each study or outcome. Please ensure this is provided for each domain or parameter assessed. For example, if you used the Cochrane risk-of-bias tool for randomized trials, provide answers to each of the signalling questions for each study. If you used GRADE to assess certainty of evidence, provide judgements about each of the quality of evidence factor. This should be provided for each outcome.

An explanation of how missing data were handled.

This information can be included in the main text, supplementary information, or relevant data repository. Please note that providing these underlying data is a requirement for publication in this journal, and if these data are not provided your manuscript might be rejected.

Response 3:

Thank you for the reminder. We have updated the manuscript to include the required information regarding PLOS ONE's policy on Data Availability. We have now included a numbered table listing all studies identified in the literature search, including those excluded from the analysis and the reason for their exclusion. Please see S4 table. One of the included studies, Byrne 2005, is a PhD thesis, and we have now provided a URL link to this source. We have now also included an appendix (S3 Appendix), showing data extracted from the primary research sources, including the name of the data extractors and the date of data extraction, and confirmation that the study was eligible to be included in the review. All the data needed to replicate our analyses were obtained from publicly available primary sources, including journal articles and clinical trials registries. These data are available in S1 and S2 appendices. We have now included the completed risk of bias assessments for each study, along with the answers to the signalling questions, available in S7 Table. We have included a table showing the certainty assessments for each of each outcome, available in S9 table. We explained how missing data were handled, including seeking information from original study authors and imputing missing data. For further details, please see page 12, lines 264-267.

Comment 4:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response 4:

Thank you for pointing this out. We have updated the references in line with PLOS ONE's guidelines. We have reviewed the references with regards to volume number, page numbers, and article identifiers. We removed Montero-Odasso et al. 2021, titled ‘New horizons in falls prevention and management for older adults: a global initiative,’ from the list of included studies, as it was mistakenly included and did not meet our inclusion criteria. When reviewing the references we identified two duplicate references and these were removed (Tamblyn et al. 2012 and Elley et al. 2008). Additionally, we identified that we had referenced multiple versions of the Cochrane handbook. Therefore, we removed references to Cochrane Handbook version 6.3 from 2022 and earlier versions, and we now cite the correct version that we used, version 6.4 from 2023. We did not cite any retracted articles.

Response to Reviewer 1

Comment 1:

Abstract:

Please clarify the statement that the effect on medications was uncertain. Methods did not describe a search for effects on any medication. Page 10 of the manuscript describes monitoring use of "fall-risk increasing drugs”. It may help to mention this in the abstract so readers know what type of medications were measured/reported.

The statement, “CDS interventions may reduce fall injury rate in older adults aged between 65 and 80 years (RaR 0.80; 95% CI 0.59, 1.09)” does not seem accurate because the confidence interval crosses the 1.0 value. Please consider restating this

If I understand the data correctly, it may be more accurate to change the last sentence of the Abstract to: “but the evidence on fall injury rate in community-dwelling patients aged 80 years or older was very uncertain.” In other words, CDS use worked well in hospitals and residential care, but the effect was not statistically significant in community dwelling patients. This is such an important observation that it needs to be clear here and in the Conclusion of the Abstract on Page 3.

Response 1:

Thank you for pointing this out. We have now added details of the primary outcomes of the systematic review in the methods section of the abstract, including medication outcomes, which consisted of medication review and prescribing. Please see page 2, lines 42-44. In the results section of the abstract, we replaced the statement, “however the effect on medication outcomes was very uncertain,” with “…and medication review and prescribing (all nine comparisons favouring CDS; 95% CI 70%, 100%; low certainty).” Please see page 2, lines 51-53.

Regarding the statement, “CDS interventions may reduce fall injury rate in older adults aged between 65 and 80 years (RaR 0.80; 95% CI 0.59, 1.09),” GRADE guidance suggests that findings should be communicated based on the point estimate and the certainty of evidence [1]. Our best estimate indicates a 20% reduction in fall injury rate, which, together with the low certainty of evidence for this outcome, supports our decision to keep the original phrasing. We hope this explains our choice. If the reviewer still feels this interpretation is incorrect, we are open to reconsider and making necessary changes. We have now clarified in the methods section that results are described in line with GRADE guidance, including a brief explanation of the approach, along with the Santesso reference [1]. Please see page 13, lines 279-281. We have now also included the certainty of evidence rating when reporting the results in the results section of the abstract. Please see pages 2-3, lines 49-61.

Thank you for highlighting the results of CDS interventions among community-dwelling older adults and the uncertainty regarding to fall injuries. We appreciate your insight and have revised the conclusion section of the abstract to emphasize the finding that CDS interventions may reduce falls in hospitals and residential care settings, but likely not in community-dwelling older adults. We have also emphasized the uncertainty of CDS interventions’ effects on fall injury rates in adults aged 80 years or older. Please see page 3, lines 63-70.

Comment 2:

Manuscript (MS)

Please check grammar throughout the MS. For example, Page 4, Introduction line 2 “leading” should be “leads”. This is an important, well-done study, potentially affecting important clinical and health economic outcomes. Grammatical errors distract from its credibility and potential clinical use.

I do not have time to address every grammatical error. This needs review by a good editor.

Response 2:

Thank you for your feedback. We have corrected the sentence in the second line of the introduction; please see page 4, lines 92-93. Additionally, we have reviewed the manuscript and addressed the grammatical errors we identified.

Response to Reviewer 2

Comment 1:

This systematic review and meta-analysis is an important contribution to the literature on fall prevention in older adults using CDS interventions.

The methodology is rigorous, and the conclusions are generally well-supported by the evidence.

Strengths include the comprehensive search, transparent methods, proper use of meta-analytic techniques, subgroup analyses, and the application of GRADE.

Minor points for improvement:

Discussion clarity: Some explanations regarding the difference between fall rate and fall risk outcomes could be streamlined to enhance reader understanding.

Graphical presentation: Figures could be slightly improved to enhance readability (e.g., legends and risk of bias charts could be made larger for clarity).

No ethical concerns were identified.

No concerns regarding plagiarism, redundant publication, or data fabrication were noted.

Recommendation:

Minor revision (language polishing in Discussion and minor graphical improvements).

Response 1:

Thank you for your positive feedback on our systematic review and meta-analysis. We appreciate your recognition of our rigorous methodology. We have revised the manuscript to better explain the differences between fall risk and fall rate outcomes. Specifically, we have clarified the difference between fall risk and fall rate in the methods section; please see page 9, lines 197-203. We have also clarified how interventions might have a different impact on the rate of falls versus fall risk; please see pages 30-31, lines 612-626. We have enlarged the legends and the risk of bias charts to enhance readability. Please see Figs 2-5.

References

1. Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119: 126–135. doi:10.1016/j.jclinepi.2019.10.014

Attachment

Submitted filename: Response to Reviewers.docx

pone.0340025.s021.docx (53.2KB, docx)

Decision Letter 1

Nishant Jaiswal

8 Aug 2025

Dear Dr. Solli,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Nishant Premnath Jaiswal, MBBS, PhD

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

Reviewer #3: Partly

Reviewer #4: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

Reviewer #2: This manuscript addresses an important and timely topic: the effectiveness of Clinical Decision Support (CDS) systems in fall prevention among older adults. The systematic review and meta-analysis are well designed, and the authors follow rigorous methods aligned with PRISMA and GRADE guidelines. However, several aspects require major attention before the manuscript can be considered for publication... Language and Grammar (Essential Revision):

The manuscript still contains numerous grammatical and syntactical issues that reduce clarity and weaken its impact. A professional English language editing is essential, especially in the Introduction and Discussion sections. For example:

Line 93: “Falls can cause significant health loss that leads to more complex care requirements” → awkward phrasing.

Line 92: “Falls are a major cause of morbidity and mortality…” → avoid redundancy by rephrasing the following lines more concisely.

GRADE Interpretation (Overstatement):

The authors frequently describe outcomes with low or very low certainty as "may improve" or "likely reduce." While this aligns with GRADE semantics, the consistent use of optimistic phrasing throughout the abstract and conclusion may mislead readers about the strength of evidence. I strongly recommend a more cautious tone, especially for:

Medication outcomes: classified as “low certainty” but still interpreted positively.

Fall injury in those 65–80 years: RaR 0.80 with CI crossing 1.00 should be clearly described as statistically non-significant.

Methodological Transparency:

The authors claim no language restriction, but earlier versions included a list of included languages. Ensure this inconsistency is corrected in both the Methods and Appendices.

Risk of bias assessments are now available in S7 Table, but summary RoB graphs in the main text are difficult to interpret (small font, unclear legends). Please improve readability and ensure consistency between main text and supplements.

Data Completeness (Minor):

The explanation for handling missing data is too brief. Please detail the imputation procedures used and specify how often author contact led to data retrieval.

Figures and Tables:

Figure readability is still suboptimal despite the revisions. Font sizes and labeling in forest plots and risk-of-bias visuals should be increased for clarity, especially for print versions.

Minor Points:

Use consistent terminology: sometimes "CDS systems" is used redundantly (the "S" already stands for "system").

Add a visual summary table of GRADE certainty per outcome (possibly alongside S9 Table) in the main manuscript for quick reference.

Discuss potential implementation barriers to CDS in LMIC settings – currently the review is biased toward high-income contexts.

Overall Recommendation:

Minor Revision – Language and Presentation Improvements Required.

Reviewer #3: Thank you for acknowledging the reviewers comment and your revisions. The paper looks better, but I still have a number of issues/questions:

Pg. 5 ln 118 - Suggest changing to "Generally, the use of CDS by healthcare ...."

Pg 5 ln 121 - suggest changing to "patients [32], medication outcomes in older adults [33,34], and adults in general.

Pg 6 ln 134 - suggest changing to "This systematic review aimed to evaluate the effects of CDS for...."

Pg 8 ln 172 - since your inclusion criteria included restrictions on the type of studies for inclusion in the review, please clarify why you did not include restrictions on the study design within your search strategy?

Pg 10 ln 208 - Why did you include studies which did not specify one of your required outcomes?

Pg 14 ln 301 - what do you mean by the phrase "to a median (min-max) of 1 433 (312-46245) patient participants?

Pg 24 ln 460 - your interpretation of the impact of CDS on falls in hospital/residential care, although was significant, needs to include the considerable heterogenity present.

Pg 24 ln 466-478 - your interpretation of the sub group analysis I feel is inaccurate and likely do not reduce the rate of falls.

Pg 28 ln 572-574 - your results do not reflect that CDS does not reduce falls in pts >80

Pg 33 - Strengths and limitations section - please expand more on limitations of the review

Pg 34.

Reviewer #4: Reviewer comments

Thank you for the opportunity to review this revised manuscript. I did not review the original version but have examined the responses to the previous reviewer comments and have reviewed the revised version anew from my perspective.

I did not verify that all requests by the Academic Editor were addressed, but notice that the author did not add any information into the manuscript, as stated in their response, about any methods for author contact for missing outcome data. If they did perform author contact, the means (eg email first author) and frequency should be stated.

Responses to reviewers 1 and 2. The comments to the previous reviewer comments are mostly addressed, though as indicated below more work should be done to define the author’s GRADE approach.

The review is well done and will be improved in my opinion with some minor changes and consideration of one major comment on GRADE. My comments:

Minor comments:

Abstract: i) please note the search date(s), ii) if space permits it would be excellent to provide a brief overview of the types of CDS interventions used most, iii) please see below for some suggestions and questions about the GRADE approach which may influence the reporting of results in the abstract

Introduction: stating that “interventions to prevent falls” are cost-effective and effective in falls and fall injuries could be more specific especially since not all interventions have been shown successful and the authors are arguing for a review of CDS interventions. Possibly “a variety of interventions aimed at older adults” or such would help.

Materials and methods:

1. Was the protocol only ever “drafted”? even if there were changes post hoc the protocol should have been in some form of final version before starting the review.

2. Spell out PRISMA at first use

3. Selection process: please add details about who conducted full text review, and confirm whether consensus was required at title/abstract stage or just full text.

4. Data collection process: using verification for only 5 of 24 papers should be noted in the discussion as a limitation of the review (possibility for errors). Duplicate extraction or verification of all data is a standard for systematic reviews. This is particularly concerning if only one person chose which outcome data to use when studies reported on multiple outcomes.

5. Study risk of bias: please confirm if “the main outcome results” means the result data used for each outcome of interest to the review, or otherwise.

6. Synthesis methods: please add a section on unit of analysis issues, i.e. what was done to account for effects of clustering in cluster RCTs? Was the authors’ result adjusted for clustering used for analysis and, if not reported/performed, what was done?

Results/conclusions:

1. it would be of interest to comment on how many studies had eligibility criteria related to increased risk for falls (e.g. previous fallers, 1+ risk factor etc), and to state whether the findings overall are most applicable to populations at increased risk (this may vary by outcome to some degree),

2. it is hard to know whether the findings for the fall risk outcome may be most applicable to certain settings or ages; can the authors comment on whether the 10 studies appeared to capture both settings and ages fairly well? For example, if the large majority of the participants in the analysis came from studies undertaken in residential/acute care there could be some concerns about directness to the entire population of interest (eg rating down for indirectness may apply) or some way to clarify this observation for the reader,

3. likewise with setting and age groups for fall rates is there any indication that the studies in residential/acute care also enrolled older people to help know whether findings could be most applicable to both setting and age combined?,

4. conversion of ORs to absolute risk difference (for falls risk) should first convert the OR to a RR (see appendix 3 in https://www.bmj.com/content/389/bmj-2024-081904),

5. the authors should speak to their reason for use of a separate study (ref 88) for control event rates (rather than the studies themselves) and describe this study in some detail,

6. in figure 2 there are some “FU” and “follow-up” so this could be made consistent; further the authors should be able to put something into the figure for the medication outcome findings for the Blalock study, even if just a narrative statement by the authors about the direction of effect,

7. for mortality and hospitalizations the reversion to relying on statistical significance goes against what was done for other outcomes; perhaps the authors comment about any directions of effect, speak to the small sample sizes for these rare outcomes and point again to where folks can find the results if they want.

Line 561-2: would suggest deleting this sentence since the authors did not assess the magnitude of effects in their review

Major comment:

GRADE does not asses the certainty of the point estimate per se but it’s relation to the “target” of certainty which should be defined in the methods section (see GRADE 34 guidance and J Clin Epidemiol. 2017 Jul:87:4-13. doi: 10.1016/j.jclinepi.2017.05.006 and BMJ. 2025 Apr 29:389:e081904. doi: 10.1136/bmj-2024-081904). For the provider outcomes, the target would need to be a direction of effect only since the analysis did not assess magnitude. For the patient outcomes, this could have been the null (direction of effect) or some form of a minimally important difference (even if approximate), especially to help determine whether findings are “little to no difference” or “an affect”. It appears the authors just used direction of effect and if so this should be mentioned and the findings should be stated in this light. It is confusing what the authors have done for this since there is no statement in the methods and for falls risk (OR 0.93, 21 fewer fallers per 1000) they state little to no effect in the results (implying 21 fewer is below some threshold of an MID) but a slight reduction in the abstract and discussion.

The choice of the target can change the GRADE ratings for all domains but in particular inconsistency and imprecision. For the provider outcomes, rating a conclusion of direction of effect where all studies showed the same direction would suggest against rating down for inconsistency; the size of effect doesn’t matter for this target. With some of the effects not being statistically significant/precise for the direction there could be concern over imprecision but it may not be serious. For direction of effect for adherence, I would think low certainty overall seems appropriate with the text indicating rating down twice for ROB. The same applies for medication outcomes, unless the authors want to have a third category of No direction which a couple of the findings indicate (e.g. Blum & Lightbody) and where some inconsistency in direction could be noted. If the authors really think low certainty for the direction is appropriate (vs moderate with just serious ROB) they could consider rating down twice for ROB or possibly once for ROB and once for imprecision (as above) or inconsistency (noting really that a direction was not shown in a couple of cases). For the falls risk outcome, if the authors are rating certainty in direction of effect, then not rating down for imprecision makes sense (assuming they wouldn’t be too strict on the upper limit of the 95% CI crossing the null slightly) and they would conclude there is an effect (possibly mentioning that it may not be important), but if they want to say there is “little to no” difference (implying use of an MID and that the point estimate is below this) then they likely should state what the MID was and make sure the entire 95% CI does not contain this value or else also rate down for imprecision. For the falls rate outcomes, if using a direction of effect the authors should note this in their conclusions whereas if they think the magnitude is at least as large as some small but important effect they may also rate down for either inconsistency (since ~30% of the weight in the analysis showed effects below what might be considered an MID) or for imprecision if the lower limit of the 95%CI (81 fewer falls) does not surpass their MID.

In summary, having a clear statement about what the authors were rating their certainty in (e.g. null/direction of effect) would be good as well as re-considering their assessments for the provider outcomes in light of this (not rating down for inconsistency). If using the direction of effect their falls risk findings should likely be “an effect”, with a comment that the effects may be small. If MIDs were applied these should be stated with the above considerations added.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2026 Jan 12;21(1):e0340025. doi: 10.1371/journal.pone.0340025.r004

Author response to Decision Letter 2


21 Sep 2025

Response to Reviewers

Dear Dr. Nishant Premnath Jaiswal

Thank you for the opportunity to submit a revised draft of our manuscript titled "Effectiveness of clinical decision support in fall prevention among older adults: a systematic review and meta-analysis" to PLOS ONE. We greatly appreciate the time and effort you and the reviewers have dedicated to providing thoughtful and constructive feedback. We have carefully considered all comments and made revisions to address the suggestions provided.

All authors have reviewed and approved the submission of the revised manuscript. The manuscript has not been published and is not being considered for publication elsewhere, in whole or in part, in any language. We hope you will now be able to accept the article for publication in your journal.

Thank you for your consideration.

Yours sincerely

Rune Solli on behalf of the authors

Response to Reviewer 2

Comment 1:

This manuscript addresses an important and timely topic: the effectiveness of Clinical Decision Support (CDS) systems in fall prevention among older adults. The systematic review and meta-analysis are well designed, and the authors follow rigorous methods aligned with PRISMA and GRADE guidelines. However, several aspects require major attention before the manuscript can be considered for publication... Language and Grammar (Essential Revision):

The manuscript still contains numerous grammatical and syntactical issues that reduce clarity and weaken its impact. A professional English language editing is essential, especially in the Introduction and Discussion sections. For example:

Line 93: “Falls can cause significant health loss that leads to more complex care requirements” → awkward phrasing.

Line 92: “Falls are a major cause of morbidity and mortality…” → avoid redundancy by rephrasing the following lines more concisely.

Response 1:

Thank you for this comment. In response to your feedback, the manuscript has undergone professional English language editing by a native English speaker. We have carefully revised the text, particularly the Introduction and Discussion sections, to improve clarity and address the issues you identified.

Comment 2:

GRADE Interpretation (Overstatement):

The authors frequently describe outcomes with low or very low certainty as "may improve" or "likely reduce." While this aligns with GRADE semantics, the consistent use of optimistic phrasing throughout the abstract and conclusion may mislead readers about the strength of evidence. I strongly recommend a more cautious tone, especially for:

Medication outcomes: classified as “low certainty” but still interpreted positively.

Fall injury in those 65–80 years: RaR 0.80 with CI crossing 1.00 should be clearly described as statistically non-significant.

Response 2:

Thank you for your comment on the interpretation of outcomes with low or very low certainty. We acknowledge that the repeated use of phrases such as “may improve” or “likely reduce” throughout the abstract and conclusion could potentially convey an overly optimistic impression. To address this, we have carefully reviewed the text and revised it ensure a more cautious and neutral tone, particularly for outcomes with low or very low certainty, to align with your suggestion and avoid the risk of misleading readers. Please see the updated text. We have explicitly described the result on fall injuries in those aged 65 to 80 years as statistically non-significant. Please see page 29, lines 556-557.

Comment 3:

Methodological Transparency:

The authors claim no language restriction, but earlier versions included a list of included languages. Ensure this inconsistency is corrected in both the Methods and Appendices.

Risk of bias assessments are now available in S7 Table, but summary RoB graphs in the main text are difficult to interpret (small font, unclear legends). Please improve readability and ensure consistency between main text and supplements.

Response 3:

Thank you for your comment regarding language restrictions. No language restrictions were imposed on the literature searches. In response to a previous Editor request, we removed the list of languages to avoid the implication that language restrictions had been applied. We have reviewed the methods section and Appendices to ensure consistency throughout. Additionally, we have revised the summary RoB graphs to improve readability, including increasing font sizes and clarifying legends, and to ensure consistency between the main text and supplements.

Comment 4:

Data Completeness (Minor):

The explanation for handling missing data is too brief. Please detail the imputation procedures used and specify how often author contact led to data retrieval.

Response 4

Thank you for your comment. We have expanded the Methods section to clarify that we contacted the corresponding authors of eight reports to obtain missing data, with up to three email attempts per author. Data retrieval was successful in four instances, and no data imputation was performed. Please see page 10, lines 208-213.

Comment 5:

Figures and Tables:

Figure readability is still suboptimal despite the revisions. Font sizes and labeling in forest plots and risk-of-bias visuals should be increased for clarity, especially for print versions.

Response 5:

Thank you for your comment. We have revised the figures to improve their readability in both the main text and supplementary materials, with particular attention to ensuring clarity in print versions. Font sizes and labelling in the forest plots and risk-of-bias visuals have been increased for enhanced clarity.

Comment 6:

Minor Points:

Use consistent terminology: sometimes "CDS systems" is used redundantly (the "S" already stands for "system").

Add a visual summary table of GRADE certainty per outcome (possibly alongside S9 Table) in the main manuscript for quick reference.

Discuss potential implementation barriers to CDS in LMIC settings – currently the review is biased toward high-income contexts.

Response 6:

Thank you for your observation regarding terminology. For clarity, in this manuscript, we have defined “CDS” as “clinical decision support” and have carefully reviewed the text to ensure consistent use and avoid any potential confusion.

We have added a GRADE summary of findings table in the manuscript for quick reference. Please see Table 4.

Thank you for highlighting the important point about implementation in LMIC. We acknowledge that the review predominantly focuses on high-income contexts. To address this, we have added a discussion of potential implementation barriers in LMIC, including limited digital infrastructure, restricted access to electronic health records, overburdened staff, and other challenges. Please see page 35, lines 713-724.

Response to Reviewer 3

Comment 1:

Pg. 5 ln 118 - Suggest changing to "Generally, the use of CDS by healthcare ...."

Pg 5 ln 121 - suggest changing to "patients [32], medication outcomes in older adults [33,34], and adults in general.

Pg 6 ln 134 - suggest changing to "This systematic review aimed to evaluate the effects of CDS for...."

Pg 8 ln 172 - since your inclusion criteria included restrictions on the type of studies for inclusion in the review, please clarify why you did not include restrictions on the study design within your search strategy?

Pg 10 ln 208 - Why did you include studies which did not specify one of your required outcomes?

Pg 14 ln 301 - what do you mean by the phrase "to a median (min-max) of 1 433 (312-46245) patient participants?

Pg 24 ln 460 - your interpretation of the impact of CDS on falls in hospital/residential care, although was significant, needs to include the considerable heterogenity present.

Pg 24 ln 466-478 - your interpretation of the sub group analysis I feel is inaccurate and likely do not reduce the rate of falls.

Pg 28 ln 572-574 - your results do not reflect that CDS does not reduce falls in pts >80

Pg 33 - Strengths and limitations section - please expand more on limitations of the review

Response 1:

Pg. 5 ln 118 - Thank you for the suggestion. We have updated the sentence to: "Generally, the use of CDS by healthcare ..." for improved clarity.

Pg 5 ln 121 - We have revised the text accordingly.

Pg 6 ln 134 - Thank you for your suggestion. We have revised the sentence to: “This systematic review aimed to evaluate the effects of CDS for fall prevention on …”

Pg 8 ln 172 – Thank you for this observation. Our inclusion criteria restricted study types during the screening and selection phases to ensure relevance and rigor. However, we did not restrict study design in the search strategy to maximise sensitivity, as publications may not always disclose the study design.

Pg 10 ln 208 - Thank you for your questions. Studies that did not specify one of our required outcomes were excluded. We have revised Table 1 in the Methods section to clarify this decision and enhance transparency.

Pg 14 ln 301 - This phrase indicates the median number of patient participants included across the studies, with the smallest study having 312 participants and the largest having 46,245. To improve clarity, have revised this sentence to: "… to a median number of 1,433 patient participants, ranging from 312 to 46,245."

Pg 24 ln 460 – Thank you for pointing this out. We have added a sentence in the Results section to acknowledge the substantial heterogeneity and revised the Discussion section to address the considerable heterogeneity and its implications for interpretating the effects of CDS on falls in hospital/residential care settings.

Pg 24 ln 466-478 – Thank you for pointing this out. Considering comments from all reviewers, we have updated the grading of certainty to explicitly reflect the certainty in the direction of effect. Minor adjustments were made in the certainty ratings, and the corresponding statements about the results have been revised for accuracy and clarity. For further details, please see our response to comment 5 from reviewer 4.

Pg 28 ln 572-574 - Thank you for your comment. Our results reflect that CDS interventions reduce the rate of falls among patients aged 80 years or older. In accordance with GRADE methodology, we have used the term “likely” to describe findings supported by moderate certainty evidence. We have retained this wording and clarified this choice in the methods section under “Assessment of certainty of the evidence”. Please see page 14, lines 312-313 and Table 4.

Pg 33 - Strengths and limitations section - Thank you for the suggestion. We have expanded the Strengths and limitations section to include additional limitations, such as the uncertainty surrounding the specific effects of different types of CDS tools and the substantial risk of bias in most of the included studies.

Response to Reviewer 4

Comment 1

Thank you for the opportunity to review this revised manuscript. I did not review the original version but have examined the responses to the previous reviewer comments and have reviewed the revised version anew from my perspective.

I did not verify that all requests by the Academic Editor were addressed, but notice that the author did not add any information into the manuscript, as stated in their response, about any methods for author contact for missing outcome data. If they did perform author contact, the means (eg email first author) and frequency should be stated.

Response 1

Thank you for your comment. We have updated the Methods section to include details about author contact for missing outcome data. Specifically, we clarified that corresponding authors were contacted via email, with up to three follow-up attempts if necessary. Please see page 10, lines 208-211.

Comment 2

Abstract: i) please note the search date(s), ii) if space permits it would be excellent to provide a brief overview of the types of CDS interventions used most, iii) please see below for some suggestions and questions about the GRADE approach which may influence the reporting of results in the abstract

Introduction: stating that “interventions to prevent falls” are cost-effective and effective in falls and fall injuries could be more specific especially since not all interventions have been shown successful and the authors are arguing for a review of CDS interventions. Possibly “a variety of interventions aimed at older adults” or such would help.

Response 2

Thank you for these suggestions. We have added the search dates to the Methods section of the abstract, included a brief overview of the most used types of CDS, and reviewed the reporting of results in the abstract considering your suggestions regarding the GRADE approach. Please see the revised abstract. In the introduction, we have specified the types of fall prevention interventions that are cost-effective and effective in reducing falls and fall injuries. Please see pages 4-5, lines 103-107.

Comment 3:

Materials and methods:

1. Was the protocol only ever “drafted”? even if there were changes post hoc the protocol should have been in some form of final version before starting the review.

2. Spell out PRISMA at first use

3. Selection process: please add details about who conducted full text review, and confirm whether consensus was required at title/abstract stage or just full text.

4. Data collection process: using verification for only 5 of 24 papers should be noted in the discussion as a limitation of the review (possibility for errors). Duplicate extraction or verification of all data is a standard for systematic reviews. This is particularly concerning if only one person chose which outcome data to use when studies reported on multiple outcomes.

5. Study risk of bias: please confirm if “the main outcome results” means the result data used for each outcome of interest to the review, or otherwise.

6. Synthesis methods: please add a section on unit of analysis issues, i.e. what was done to account for effects of clustering in cluster RCTs? Was the authors’ result adjusted for clustering used for analysis and, if not reported/performed, what was done?

Response 3

1. Thank you for your comment. The protocol was drafted, finalised, and registered in PROSPERO before commencing the review. We have clarified this in the Methods section. Please see page 7, lines 152-156.

2. We have spelled out PRISMA at its first mention.

3. Thank you for your comment. We have added details about who conducted full-text review and clarified that consensus was required at both the title/abstract screening stage and the full-text screening stage. Please see page 9, lines 197-201.

4. Thank you for highlighting this issue. We have discussed the limited verification of collected data by a second reviewer as a limitation of the review in the Discussion section to acknowledge the possibility of errors. Additionally, we have clarified that the selection of each result was discussed and verified with the project statistician to ensure correctness and consistency. Please see page 38, lines 784-787.

5. We have specified which outcomes were assessed for risk of bias. Please see page 12, lines 253-254.

6. Thank you for your comment regarding unit of analysis issues. The cluster-randomised trials included in the review accounted for clustering in their original analyses. Additionally, in our syntheses, we ensured that only one outcome from each study was included, thus maintaining independence between studies in the analyses. We have included a sentence in the methods section to clarify this. Please see page 13, lines 291-292.

Comment 4

Results/conclusions:

1. it would be of interest to comment on how many studies had eligibility criteria related to increased risk for falls (e.g. previous fallers, 1+ risk factor etc), and to state whether the findings overall are most applicable to populations at increased risk (this may vary by outcome to some degree),

2. it is hard to know whether the findings for the fall risk outcome may be most applicable to certain settings or ages; can the authors comment on whether the 10 studies appeared to capture both settings and ages fairly well? For example, if the large majority of the participants in the analysis came from studies undertaken in residential/acute care there could be some conce

Attachment

Submitted filename: Response_to_Reviewers_auresp_2.docx

pone.0340025.s022.docx (63.8KB, docx)

Decision Letter 2

Sascha Köpke

10 Oct 2025

Dear Dr. Solli,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

We look forward to receiving your revised manuscript.

Kind regards,

Sascha Köpke

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

Reviewer #2: This manuscript addresses a highly relevant topic, considering the growing prevalence of falls among older adults and the urgent need for effective interventions. The systematic review and meta-analysis presented demonstrate methodological rigor, including a comprehensive search strategy across multiple databases, application of the GRADE approach, and appropriate use of meta-analytic techniques.

Strengths

Comprehensive and transparent search strategy.

Clearly defined inclusion criteria, encompassing different study designs.

Robust synthesis of the data, including both meta-analyses and risk of bias assessment.

Discussion aligned with the presented evidence, highlighting differences between settings (hospital/residential care versus community).

Suggestions for Improvement

Clarity on outcomes: The explanation of the difference between “fall rate” and “fall risk” could be made more concise and accompanied by practical examples to improve readability for a broader audience.

English language polishing: Although the manuscript has been revised, some sentences could be more fluent and precise. A professional language editing service is recommended.

Graphical presentation: Figures and tables have been improved, but further adjustments could increase readability, such as standardizing font size and enlarging legends, especially for risk-of-bias charts.

Practical conclusions: It would strengthen the paper to explicitly emphasize in the discussion the clinical and implementation implications across different settings (primary care versus hospital/residential), to enhance the translation of findings into practice.

Overall, this is a technically sound study with data that support its conclusions. It represents a valuable contribution to the literature on fall prevention in older adults. I recommend acceptance after minor revisions, mainly focusing on clarity of writing, conceptual distinction between outcomes, and minor graphical improvements.

Reviewer #3: Thank you for resubmitting your revised manuscript, and you have taken into consideration the reviewers feedback. I do have some ongoing feedback /questions which is included in the document which is around:

1. The final number of included studies reported in the manuscript is different to that reported in the PRISMA diagram - please clarify the actual number.

2. Your eligibility criteria is confusing - your report only including studies based in healthcare settings, yet you included community dwelling studies?

3. I do not agree with all your interpretations about the results obtained - you indicate that CDS may reduce fall rate across all age groups and settings, yet this is not supported by your results. Please re-evaluate this.

Reviewer #4: Good revision. Only 2 minor comments for revision. 1. for the GRADE rating of injurious falls in the 80+ age category, there should only be one level rated down for imprecision since the effect shows harm (magnitude not relevant) with slight imprecision (0.99 lower CI limit). This won't change the overall GRADE but will add accuracy. 2. in the discussion, the beginning sentence of the patient outcomes section uses one of the 4 estimates for falls rates without a reason. Perhaps just state that the intervention may reduce fall risk (14 fewer) and fall rates (range 20-188 fewer), since you later discuss the differences across subgroups.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Attachment

Submitted filename: PONE-D-25-10237_R2_FC_OCT 6 2026.pdf

pone.0340025.s023.pdf (6.2MB, pdf)
PLoS One. 2026 Jan 12;21(1):e0340025. doi: 10.1371/journal.pone.0340025.r006

Author response to Decision Letter 3


14 Dec 2025

Response to Reviewers

Dear Dr. Sascha Köpke

Thank you for the opportunity to submit a revised draft of our manuscript titled "Effectiveness of clinical decision support in fall prevention among older adults: a systematic review and meta-analysis" to PLOS ONE. We sincerely appreciate the time and effort you and the reviewers have invested in providing thoughtful and constructive feedback. We have carefully considered all comments and made revisions to address the suggestions provided.

All authors have reviewed and approved the submission of this revised manuscript. We confirm that the manuscript has not been published and is not under consideration for publication elsewhere, in whole or in part, in any language.

We hope that the revisions meet your expectations, and we look forward to the possibility of having our article accepted for publication.

Thank you for your time and consideration.

Yours sincerely

Rune Solli on behalf of the authors

Response to Reviewer 2

Comment 1:

This manuscript addresses a highly relevant topic, considering the growing prevalence of falls among older adults and the urgent need for effective interventions. The systematic review and meta-analysis presented demonstrate methodological rigor, including a comprehensive search strategy across multiple databases, application of the GRADE approach, and appropriate use of meta-analytic techniques.

Strengths

Comprehensive and transparent search strategy.

Clearly defined inclusion criteria, encompassing different study designs.

Robust synthesis of the data, including both meta-analyses and risk of bias assessment.

Discussion aligned with the presented evidence, highlighting differences between settings (hospital/residential care versus community).

Suggestions for Improvement

Clarity on outcomes: The explanation of the difference between “fall rate” and “fall risk” could be made more concise and accompanied by practical examples to improve readability for a broader audience.

English language polishing: Although the manuscript has been revised, some sentences could be more fluent and precise. A professional language editing service is recommended.

Graphical presentation: Figures and tables have been improved, but further adjustments could increase readability, such as standardizing font size and enlarging legends, especially for risk-of-bias charts.

Practical conclusions: It would strengthen the paper to explicitly emphasize in the discussion the clinical and implementation implications across different settings (primary care versus hospital/residential), to enhance the translation of findings into practice.

Overall, this is a technically sound study with data that support its conclusions. It represents a valuable contribution to the literature on fall prevention in older adults. I recommend acceptance after minor revisions, mainly focusing on clarity of writing, conceptual distinction between outcomes, and minor graphical improvements.

Response 1:

Thank you for your feedback. We have clarified the explanation of the difference between “fall rate” and “fall risk” in the Methods, Results, and Discussion sections. Please see page 10, lines 214-221; page 24, lines 438-439; and pages 33-34, lines 663-683. Additionally, we have included a practical example to enhance clarity, which can be found on page 33, lines 673-677.

Thank you for your comment regarding the language of the manuscript. As a reminder, the manuscript underwent professional language editing during the previous revision round. However, we have carefully reviewed the text again in this round to further improve fluency and precision. We hope that the revised manuscript meets the required expectations.

Graphical presentation: Thank you for this suggestion. We appreciate your feedback on improving the figures and tables. In the previous two rounds, we increased the font size and enlarged the legends for the risk-of-bias charts. We believe these figures are now clear, suitable for publication, and compliant with the journal’s submission guidelines regarding figures. However, please let us know if there are any specific aspects that still require further adjustments.

Practical conclusions: Thank you for this valuable suggestion. We have revised the discussion section to explicitly emphasize the clinical and implementation implications of our findings across different settings. Please see the updated Discussion section on page 38, lines 782-795.

Response to Reviewer 3

Comment 1:

Thank you for resubmitting your revised manuscript, and you have taken into consideration the reviewers feedback. I do have some ongoing feedback /questions which is included in the document which is around:

1. The final number of included studies reported in the manuscript is different to that reported in the PRISMA diagram - please clarify the actual number.

2. Your eligibility criteria is confusing - your report only including studies based in healthcare settings, yet you included community dwelling studies?

3. I do not agree with all your interpretations about the results obtained - you indicate that CDS may reduce fall rate across all age groups and settings, yet this is not supported by your results. Please re-evaluate this.

Response 1:

1. Thank you for your comment. To clarify, the PRISMA diagram shows that, from the primary literature searches, 45 reports were assessed for eligibility, of which 21 were excluded. Additionally, as described on the right side of the PRISMA diagram, nine reports were assessed for eligibility via other methods, including the Physiotherapy Evidence Database (PEDro), Google Scholar, chain searches, cited reference searches, and conference abstracts, of which five were excluded. As a result, a total of 28 publications from 25 unique studies were included in the review. We confirm that the inclusion of 28 publications from 25 unique studies is accurately reported in both the PRISMA diagram and the manuscript. We kindly ask for further clarification if there is a specific point we have misunderstood. Additionally, we have clarified the meaning of PEDro in the manuscript by writing it out in full upon its first mention.

2. Thank you for highlighting this discrepancy between the eligibility criteria in the main text and Table 1. We have revised the main text to clarify that studies conducted in any healthcare setting, as well as those conducted in the homes of older adults, were eligible for inclusion.

3. Thank you for your feedback. We have re-evaluated our interpretation of the results and revised the manuscript to ensure it does not suggest that CDS reduces fall rates across all age groups and settings. The updated Results section and revised conclusion now reflect this clarification.

Response to Reviewer 4

Comment 1

Good revision. Only 2 minor comments for revision. 1. for the GRADE rating of injurious falls in the 80+ age category, there should only be one level rated down for imprecision since the effect shows harm (magnitude not relevant) with slight imprecision (0.99 lower CI limit). This won't change the overall GRADE but will add accuracy.

Response 1

Thank you for this valuable point. We agree that only one level should be rated down for imprecision, as the confidence interval slightly crosses the null effect. We have made the necessary changes to the manuscript. Please see Table 4 and S9 Table.

Comment 2

2. in the discussion, the beginning sentence of the patient outcomes section uses one of the 4 estimates for falls rates without a reason. Perhaps just state that the intervention may reduce fall risk (14 fewer) and fall rates (range 20-188 fewer), since you later discuss the differences across subgroups.

Response 2

Thank you for pointing this out. We have revised the beginning sentence of the patient outcomes section of the Discussion as suggested, and it now states that our meta-analyses suggested a possible reduction in fall risk (ranging from 32 fewer to three more fallers) and fall rates (ranging from 20 to 188 fewer falls).

Attachment

Submitted filename: Response_to_Reviewers_auresp_3.docx

pone.0340025.s024.docx (41.6KB, docx)

Decision Letter 3

Sascha Köpke

16 Dec 2025

Effectiveness of clinical decision support in fall prevention among older adults: a systematic review and meta-analysis

PONE-D-25-10237R3

Dear Dr. Solli,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sascha Köpke

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Sascha Köpke

PONE-D-25-10237R3

PLOS One

Dear Dr. Solli,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Sascha Köpke

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. PRISMA checklist.

    (DOCX)

    pone.0340025.s001.docx (33KB, docx)
    S2 Table. Differences between protocol and review.

    (DOCX)

    pone.0340025.s002.docx (17KB, docx)
    S3 Table. Electronic searches.

    (DOCX)

    pone.0340025.s003.docx (40.9KB, docx)
    S4 Table. Excluded studies.

    (XLSX)

    pone.0340025.s004.xlsx (1.4MB, xlsx)
    S5 Table. Description of interventions and funding sources.

    (DOCX)

    pone.0340025.s005.docx (142.6KB, docx)
    S6 Table. Design factors of CDS.

    (DOCX)

    pone.0340025.s006.docx (113.8KB, docx)
    S7 Table. Risk of bias.

    (PDF)

    pone.0340025.s007.pdf (824.4KB, pdf)
    S8 Table. Individual study results.

    (DOCX)

    pone.0340025.s008.docx (53KB, docx)
    S9 Table. GRADE evidence profile.

    (DOCX)

    pone.0340025.s009.docx (47.3KB, docx)
    S1 Appendix. Data used for analyses of healthcare practitioner performance outcomes.

    (XLSX)

    pone.0340025.s010.xlsx (17.6KB, xlsx)
    S2 Appendix. Data used for meta-analyses.

    (XLSX)

    pone.0340025.s011.xlsx (46.7KB, xlsx)
    S3 Appendix. Extracted data.

    (CSV)

    pone.0340025.s012.csv (503.9KB, csv)
    S1 Fig. Funnell plot of comparison: CDS interventions vs control on fall risk.

    (PNG)

    pone.0340025.s013.png (141KB, png)
    S2 Fig. Trim-and-fill analysis of comparison: CDS interventions vs control on fall risk.

    (PNG)

    pone.0340025.s014.png (106.4KB, png)
    S3 Fig. Meta-analysis comparing CDS interventions with control on fall rate, subgroup analysis by patients’ age.

    (PNG)

    pone.0340025.s015.png (310.9KB, png)
    S4 Fig. Funnel plot of comparison: CDS interventions vs control on fall rate.

    (PNG)

    pone.0340025.s016.png (70.2KB, png)
    S5 Fig. Trim-and-fill analysis of comparison: CDS interventions vs control on fall rate.

    (PNG)

    pone.0340025.s017.png (87.5KB, png)
    S6 Fig. Meta-analysis comparing CDS interventions with control on fall rate, subgroup analysis by risk of bias.

    (PNG)

    pone.0340025.s018.png (335KB, png)
    S7 Fig. Meta-analysis comparing CDS interventions with control on fall injury rate, subgroup analysis by risk of bias.

    (PNG)

    pone.0340025.s019.png (298.1KB, png)
    S8 Fig. Meta-analysis comparing CDS interventions with control on fall injury rate, subgroup analysis by study setting.

    (PNG)

    pone.0340025.s020.png (302.8KB, png)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0340025.s021.docx (53.2KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers_auresp_2.docx

    pone.0340025.s022.docx (63.8KB, docx)
    Attachment

    Submitted filename: PONE-D-25-10237_R2_FC_OCT 6 2026.pdf

    pone.0340025.s023.pdf (6.2MB, pdf)
    Attachment

    Submitted filename: Response_to_Reviewers_auresp_3.docx

    pone.0340025.s024.docx (41.6KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES